Abstracts | 0094 | ESPE2021 | 59th Annual ESPE (ESPE 2021 Online)

Scientific Programme, ePosters & Abstracts

Previous issue | Volume 94 | ESPE2021 | Next issue

59th Annual ESPE (ESPE 2021 Online)

Online,
22 Sep 2021 - 26 Sep 2021

The 59th ESPE Annual Meeting will now be held online in September 2021.

Plenary Lectures
- A kiss before sex
- - A Kiss before Sex
    
    hrp0094pl1
- Coming soon: new drugs for treatment of youth with type 2 diabetes
- - New Drugs for Youth with Type 2 Diabetes
    
    hrp0094pl2
- Iodine deficiency: A public health issue
- - Iodine deficiency: A public health issue
    
    hrp0094pl3
- Development of novel therapies for obesity
- - Development of novel therapies for obesity
    
    hrp0094pl4
- Advances and Challenges in the Care of Transgender/Gender Diverse Youth
- - Advances and Challenges in the Care of Transgender/Gender Diverse Youth
    
    hrp0094pl5
- The current state of epigenetic research in humans: Promise and reality
- - The current state of epigenetic research in humans: Promise and reality
    
    hrp0094pl6
- Novel insights into weight regulation
- - Novel insights into weight regulation
    
    hrp0094pl7
- The long-term effects of adolescent obesity
- - The Long term effects of adolescent obesity
    
    hrp0094pl8
Symposia
- Endocrine Hypertension - Aetiology Directed Management
- - Pathogenesis of Familial and Sporadic Hyperaldosteronism: New Concepts Involving Ion Channels
    
    hrp0094s1.1
  - Abstract unavailable
    
    hrp0094s1.2
- Recent Breakthroughs in our Understanding of Calcium and Phosphate Homeostasis
- - Circadian rhythms of skeletal homeostasis.
    
    hrp0094s2.1
  - Calciotropic and non-calciotropic roles of the calcium sensing receptor
    
    hrp0094s2.2
- Management of Rare Obesity
- - Iodine deficiency: A public health issue
    
    hrp0094s3.1
  - Hypothalamic Obesity in Craniopharyngioma
    
    hrp0094s3.2
- Recent Developments in Congenital Adrenal Hyperplasia
- - Abstract unavailable
    
    hrp0094s4.1
  - Abstract unavailable
    
    hrp0094s4.2
- Novel Therapies in Endocrinology
- - Novel Therapies in the Treatment of Congenital Hyperinsulinism
    
    hrp0094s5.1
  - Abstract unavailable
    
    hrp0094s5.2
- Bone Formation: The Growth Plate and Beyond
- - Epigenetic regulation of the growth plate
    
    hrp0094s6.1
  - Growth Plate: New insights in the origin and function of the growth plate
    
    hrp0094s6.2
- The Molecular Basis of Rare Endocrine Disorders
- - Abstract unavailable
    
    hrp0094s7.1
  - Abstract unavailable
    
    hrp0094s7.2
- Management of Childhood Brain Tumours
- - Novel Insights Into the Management of Cranial Diabetes Insipidus
    
    hrp0094s8.1
  - Abstract unavailable
    
    hrp0094s8.2
- Surgical Management of Endocrine Disorders
- - Abstract unavailable
    
    hrp0094s9.1
  - Abstract unavailable
    
    hrp0094s9.2
- Pathways to Improved Diagnosis and Management of Hypothalamo-Pituitary Disorders
- - Abstract unavailable
    
    hrp0094s10.1
  - Delayed puberty: A genetic condition?
    
    hrp0094s10.2
- Calcium and Phosphate Beyond Bone
- - Phosphate toxicity: focus on medial vascular calcification
    
    hrp0094s11.1
  - Vitamin D and male reproduction
    
    hrp0094s11.2
- Epigenetics and Genetics in Endocrine Disorders
- - Epigenetics, imprinting and growth
    
    hrp0094s12.1
  - The role of genetic analysis in primary ovarian failure
    
    hrp0094s12.2
- Joint ESPE/ISPAD Symposium: Novel Technologies in the Treatment of Diabetes
- - Latest developments in closed loop technology
    
    hrp0094s13.1
  - Abstract unavailable
    
    hrp0094s13.2
Meet the Expert
- Thyroid hormone resistance syndromes
- - Thyroid hormone resistance syndromes
    
    hrp0094mte1
- Diagnosis and management of a child with pituitary adenoma
- - Diagnosis and management of a child with pituitary adenoma
    
    hrp0094mte2
- Management of a child with post-neurosurgical hyponatraemia
- - Management of a child with post-neurosurgical hyponatraemia
    
    hrp0094mte3
- Cystic Fibrosis-related diabetes
- - Cystic Fibrosis-related diabetes
    
    hrp0094mte4
- Management of MEN1 in children and adolescents
- - Management of MEN1 in Children and Adolescents
    
    hrp0094mte5
- Autoimmune endocrinopathy
- - Autoimmune endocrinopathy
    
    hrp0094mte6
- Endocrine and osteoporosis management of boys with DMD
- - Endocrine and osteoporosis management of boys with DMD
    
    hrp0094mte7
- Real-life diabetes management during exercise
- - Real-life diabetes management during exercise
    
    hrp0094mte8
How Do I
- How Do I Session 1
- - Non-Classic congenital adrenal hyperplasia (NCCAH) - From Childhood to Adulthood
    
    hrp0094hdi1.1
  - Abstract unavailable
    
    hrp0094hdi1.2
  - Abstract unavailable
    
    hrp0094hdi1.3
- How Do I Session 2
- - Abstract unavailable
    
    hrp0094hdi2.1
  - Abstract unavailable
    
    hrp0094hdi2.2
  - Advise patients on insulin dosing for real meals.
    
    hrp0094hdi2.3
Controversies
- Stem Cell Reprogramming, IPS Cells
- - Abstract unavailable
    
    hrp0094con1.1
  - Abstract unavailable
    
    hrp0094con1.2
- Should children with isolated idiopathic GHD be retested in early/mid-puberty, rather than wait until adult height is achieved?
- - Should children with isolated idiopathic GHD (IIGHD) be retested in early/mid-puberty, rather than wait until adult height is achieved? (PRO)
    
    hrp0094con2.1
  - Should children with isolated idiopathic GHD (IIGHD) be retested in early/mid-puberty, rather than wait until adult height is achieved? (AGAINST)
    
    hrp0094con2.2
GPED
- The use of long-acting insulin analogues in low and middle income countries
- - For the use of long acting insulin analogues in low and middle income countries
    
    hrp0094gped1.1
  - Abstract unavailable
    
    hrp0094gped1.2
Young Investigators
- Young Investigators
- - Identification of novel genetic causes of familial central precocious puberty
    
    hrp0094yi1.1
  - Early life events and postnatal effects from infancy to childhood
    
    hrp0094yi1.2
  - Genetics and endocrine phenotypes of the MEHMO syndrome
    
    hrp0094yi1.3
  - Genetics and endocrine phenotypes of the MEHMO syndrome
    
    hrp0094yi1.4
  - Vegf-A mRNA transfection to improve islet graft revascularization
    
    hrp0094yi1.5
Working Group Symposia
- ESPE Working Group on Bone and Growth Plate (BGP) Symposium
- - Abstract unavailable
    
    hrp0094wg1.1
  - Craniosynostoses - genes and bone biology
    
    hrp0094wg1.2
- ESPE Working Group on Obesity (OWG) Symposium
- - Environmental obesogens
    
    hrp0094wg2.1
  - Maternal obesity and offspring health
    
    hrp0094wg2.2
- ESPE Working Group on Diabetes Technology (DT) Symposium
- - Abstract unavailable
    
    hrp0094wg3.1
  - Decision Support System for the diabetologists - practical experience
    
    hrp0094wg3.2
  - The impact of fear of hyperglycemia in parents of children with type 1 diabetes mellitus on overall glycemic control
    
    hrp0094wg3.3
- ESPE Working Group on Disorders of Sex Development (DSD) Symposium
- - New insights into sex differentiation and their relevance to disorders of sex development
    
    hrp0094wg4.1
  - Advances in the Measurement of Steroid Hormones
    
    hrp0094wg4.2
- ESPE Working Group on Paediatric and Adolescent Gynaecology (PAG) Symposium
- - Deciphering the genetics of central precocious puberty
    
    hrp0094wg5.1
  - Abstract unavailable
    
    hrp0094wg5.2
- ESPE Working Group on Gender Incongruence (GI) Symposium
- - Abstract unavailable
    
    hrp0094wg6.1
  - Abstract unavailable
    
    hrp0094wg6.2
- ESPE Working Group for Paediatric Endocrine Nurses (ESPEN) Symposium
- - Abstract unavailable
    
    hrp0094wg7.1
  - Abstract unavailable
    
    hrp0094wg7.2
  - Nursing care for the child with gender dysphoria
    
    hrp0094wg7.3
- ESPE Working Group on Turner Syndrome Symposium
- - Abstract unavailable
    
    hrp0094wg8.1
  - Turner syndrome and hormone replacement therapy
    
    hrp0094wg8.2
  - Blood Pressure in Turner Syndrome - a practical approach
    
    hrp0094wg8.3
Endo-ERN Symposium
- Endo-ERN Symposium
- - Update on the consensus on Congenital Hypothyroidism: a patient-centered approach
    
    hrp0094ern1.1
  - Patient expectation and unmet needs in XLH
    
    hrp0094ern1.2
  - Abstract unavailable
    
    hrp0094ern1.3
ESPE Yearbook Sessions
- Year of Paediatric Endocrinology 1
- - Abstract unavailable
    
    hrp0094yb1.1
  - Abstract unavailable
    
    hrp0094hb1.2
  - Abstract unavailable
    
    hrp0094yb1.3
  - Growth and Growth Factors
    
    hrp0094yb1.4
  - Bone, Growth Plate and Mineral Metabolism
    
    hrp0094yb1.5
- Year of Paediatric Endocrinology 2
- - DSD and Transgender - Updates 2021
    
    hrp0094yb2.1
  - Antenatal and Neonatal Endocrinology
    
    hrp0094yb1.2
  - Abstract unavailable
    
    hrp0094yb2.3
  - Oncology and Chronic Disease
    
    hrp0094yb2.4
  - Abstract unavailable
    
    hrp0094yb2.5
- Year of Paediatric Endocrinology 3
- - Abstract unavailable
    
    hrp0094yb3.1
  - Abstract unavailable
    
    hrp0094yb3.2
  - Abstract unavailable
    
    hrp0094yb3.3
  - Abstract unavailable
    
    hrp0094yb3.4
  - Abstract unavailable
    
    hrp0094yb3.5
Henning Andersen Prize Winners
- A Global Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 36-Month Outcomes in Participants Aged <25 Years
- - A Global Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 36-Month Outcomes in Participants Aged <25 Years
    
    hrp0094ha1
- Biphasic Pattern of Circulating Reproductive Hormones in Female Infants – The Longitudinal COPENHAGEN Minipuberty Study
- - Biphasic Pattern of Circulating Reproductive Hormones in Female Infants – The Longitudinal Copenhagen Minipuberty Study
    
    hrp0094ha2
Free Communications
- Adrenal
- - Salivary profiles of 11 oxygenated androgens follow a diurnal rhythm in patients with congenital adrenal hyperplasia
    
    hrp0094fc1.1
  - Variation of glucocorticoid dose and biomarkers in children with congenital adrenal hyperplasia - longitudinal analysis of real world data from the I-CAH registry
    
    hrp0094fc1.2
  - Re-appraising the use of urinary steroid profiles for assessing therapy control in children with 21-hydroxylase deficiency - results from the CAH-UK cohort study
    
    hrp0094fc1.3
  - Acute Illness and Death in Children with Adrenal Insufficiency
    
    hrp0094fc1.4
  - Outcome of COVID-19 infections in patients with adrenal insufficiency
    
    hrp0094fc1.5
  - Tumor DNA methylation profiling as a prognostic marker for pediatric patients with adrenocortical tumors
    
    hrp0094fc1.6
- Fat, Metabolism and Obesity
- - Efficacy and Safety Results of a Phase 2 Trial of Setmelanotide in Obesity Due to SH2B1 Variants and 16p11.2 Deletion Syndrome
    
    hrp0094fc2.1
  - Phase 3 Trial of Setmelanotide in Participants With Bardet-Biedl Syndrome: Placebo-Controlled Results
    
    hrp0094fc2.2
  - A Phase 2 Trial of the Melanocortin-4 Receptor Agonist Setmelanotide in Obesity Due to SRC1 Insufficiency: Body Weight, Body Mass Index Z Score, and Safety Results
    
    hrp0094fc2.3
  - PTEN germline mutations lead to adipose tissue overgrowth mediated via FOXO1 and SREBP1.
    
    hrp0094fc2.4
  - Reference values for longitudinal body composition in children aged 0-5 years, using Dual-energy X-ray (DXA) absorptiometry
    
    hrp0094fc2.5
  - Association between MRI Evidence of Hypothalamic Gliosis and Pubertal Development in Girls with Obesity
    
    hrp0094fc2.6
- Growth Disorders
- - iPPSD: focus on neonatal features, preliminary data from a retrospective analysis of a large cohort of patients.
    
    hrp0094fc3.1
  - Identification of a FBN1 variant in a pedigree affected with Severe Short Stature with a Mild Form of Geleophysic Dysplasia Type 2
    
    hrp0094fc3.2
  - Genetic characterization of a cohort of children with short stature
    
    hrp0094fc3.3
  - Prospective genetic analysis by a targeted gene panel of a cohort of patients classified as idiopathic short stature (ISS)
    
    hrp0094fc3.4
  - Clinical profiles and genetic spectra of 814 Chinese children with short stature
    
    hrp0094fc3.5
  - Growth patterns in children with Mucopolysaccharidosis type I-Hurler after haematopoietic stem cell transplantation: comparison with untreated patients
    
    hrp0094fc3.6
- Diabetes
- - Role of physical activity and sedentary behavior on early markers of cardiovascular disease in Canadian adolescents with and without type 1 diabetes: the CARDEA study
    
    hrp0094fc4.1
  - A Randomised Controlled Cross-Over Trial of the Hybrid Closed-Loop Insulin Delivery System Diabeloop vs. Sensor-Augmented Pump Therapy in Children Aged 6-12 Years
    
    hrp0094fc4.2
  - Aldosterone and pro-atrial natriuretic peptide kinetics in response to rehydration in children with diabetic ketoacidosis
    
    hrp0094fc4.3
  - Effect of newer CFTR modulator therapy on glycaemic control in adolescents with CFRD
    
    hrp0094fc4.4
  - Molecular Genetic Diagnosis and Research of Candidate Genes by Targeted Next Generation Sequence Analysis and Whole Exome Sequencing Method in Monogenic Diabetes: MODY-TURK Project
    
    hrp0094fc4.5
  - Clinical and genetic heterogeneity of HNF4A/HNF1A mutations in a multicentre paediatric cohort
    
    hrp0094fc4.6
- Sex Development and Gender Incongruence
- - Growth and growth reduction in transgirls
    
    hrp0094fc5.1
  - Unexpected impact of sex hormones on B-cells in trans- and cis-gendered healthy young people
    
    hrp0094fc5.2
  - Fetal Anogenital Distance (AGD) by Ultrasonography: a Marker of Early Androgen Exposure in utero?
    
    hrp0094fc5.3
  - Reproductive hormone levels in Minipuberty as a predictor of Testicular Endocrine Function and Penile Length in Healthy Young Men: An 18-year longitudinal Cohort Study
    
    hrp0094fc5.4
  - Individuals with NR5A1 (SF1) mutations and atypical sex development and their asymptomatic family member carriers are at high risk of hyposplenism
    
    hrp0094fc5.5
  - Investigation of The Molecular Genetic Causes Of Non-Syndromic Premature Ovarian Failure By Next Generation Sequence Analysis
    
    hrp0094fc5.6
- Bone and Mineral Metabolism
- - Evaluation of the potential benefits of biphosphonate treatment on symptomatic vertebral fractures in children treated for acute lymphoblastic leukemia
    
    hrp0094fc6.1
  - Long-term effectiveness of PTH(1-34) infusion therapy for autosomal dominant hypocalcaemia type 1.
    
    hrp0094fc6.2
  - Off-label use of cinacalcet in pediatric primary hyperparathyroidism: a French multi-centre experience
    
    hrp0094fc6.3
  - Use of Aids, Assistive Devices and Adaptations (AADAs) by Individuals Aged <25 Years with Fibrodysplasia Ossificans Progressiva (FOP): 36-Month Results from a Global Natural History Study (NHS)
    
    hrp0094fc6.4
  - What is the natural history of cervicomedullary compression without signal change in infants with achondroplasia? Investigating foramen magnum stenosis evolution.
    
    hrp0094fc6.5
  - Use of lateral DEXA scanning for identifying and monitoring vertebral fractures in patients affected by Duchenne Muscular Dystrophy.
    
    hrp0094fc6.6
- Fetal Endocrinology and Multisystem Disorders
- - The Use Of e-REC For Capturing The Occurrence Of COVID-19 Infections In People With Rare Endocrine Conditions
    
    hrp0094fc7.1
  - Maternal, rather than fetal, genetic variation in vitamin D metabolism is associated with umbilical cord blood 25-hydroxyvitamin D in pregnancies supplemented with cholecalciferol: findings from the MAVIDOS randomized controlled trial
    
    hrp0094fc7.2
  - European Training Requirements for Competency in Paediatric Endocrinology and Diabetes 2021
    
    hrp0094fc7.3
  - Endocrine sequelae in 157 paediatric survivors of haematopoietic stem cell transplantation
    
    hrp0094fc7.4
  - Rituximab therapy in Rapid-Onset Obesity, Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD) Syndrome
    
    hrp0094fc7.5
  - Reassessment of 18F-DOPA PET cut-offs in congenital hyperinsulinism
    
    hrp0094fc7.6
- Neuroendocrinology
- - Combined omic analysis revealed autism-linked NLGN3 as new candidate gene associated to GnRH neuron development and disease.
    
    hrp0094fc8.1
  - Recessive PRDM13 mutations result in hypogonadotropic hypogonadism and cerebellar hypoplasia
    
    hrp0094fc8.2
  - A novel clinical risk score that can accurately predict recurrence of craniopharyngioma - a multicentre cohort study
    
    hrp0094fc8.3
  - Cerebral infarction in childhood-onset craniopharyngioma patients: results of KRANIOPHARYNGEOM 2007
    
    hrp0094fc8.4
  - Bardet-Biedl Syndrome: A retrospective study of progression through puberty
    
    hrp0094fc8.5
  - Efficacy and Safety of Corifollitropin Alfa in Combination with Human Chorionic Gonadotropin for Initiation or Restoration of Puberty in Adolescent Males Aged 14 to < 18 Years with Hypogonadotropic Hypogonadism
    
    hrp0094fc8.6
- Growth Hormone and IGFs
- - How to interpret growth hormone stimulation test results in children and adolescents with overweight and obesity? A systematic review and meta-analysis and evidence-based proposal for weight-status adjusted cut-offs
    
    hrp0094fc9.1
  - A simple model with height and age at start of treatment with recombinant human growth hormone can accurately predict future growth in children with growth disorders
    
    hrp0094fc9.2
  - Once-weekly somapacitan versus daily growth hormone in growth hormone deficiency: 3 year efficacy and safety results from REAL 3, a randomised controlled phase 2 trial
    
    hrp0094fc9.3
  - Optimising adherence using a connected injection device can improve growth outcomes: Evidence from real-world data on 11 million injections in 20,000 patients with growth disorders
    
    hrp0094fc9.4
  - Dynamic Changes in Growth and IGF-I During the First Year of Life; A Longitudinal Study of 233 healthy Danish Infants
    
    hrp0094fc9.5
  - Impact of pre-transplant serum-IGF-1 on hematopoietic stem cell transplantation outcome in pediatric cancer patients
    
    hrp0094fc9.6
- Thyroid
- - Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre.
    
    hrp0094fc10.1
  - Prevalence and outcome of Congenital Central Hypothyroidism: A Multicenter Study
    
    hrp0094fc10.2
  - Genetic analyses in patients having congenital hypothyroidism with gland-in-situ by next-generation sequencing
    
    hrp0094fc10.3
  - Towards a novel genetic model for Congenital Hypothyroidism due to thyroid dysgenesis
    
    hrp0094fc10.4
  - Adjuvant Rituximab - exploratory trial in young people with Graves’ disease
    
    hrp0094fc10.5
  - Clinical features and long-term follow up of childhood papillary thyroid cancer (PTC): a single reference-center experience
    
    hrp0094fc10.6
ePoster Category 1
- Adrenal A
- - Optimizing the timing of highest hydrocortisone dose in children and adolescents with 21-hydroxylase deficiency
    
    hrp0094p1-1
  - Adrenocortical hormone profiles do not predict the molecular etiology in non-CAH primary adrenal insufficiency
    
    hrp0094p1-2
  - Growth-Related Characteristics of Patients <18 Years of Age with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (21OHD): Real-World Evidence from the I-CAH Registry
    
    hrp0094p1-3
  - Depression among insured children and young adults in the United States with congenital adrenal hyperplasia
    
    hrp0094p1-4
  - Alterations in resting-state functional connectivity in patients with congenital adrenal hyperplasia
    
    hrp0094p1-5
  - International practice of therapy monitoring in congenital adrenal hyperplasia - Real World data from the I-CAH registry
    
    hrp0094p1-6
  - Brain activity during working memory in congenital adrenal hyperplasia
    
    hrp0094p1-7
  - Long-term Cardiometabolic Morbidity In Young Adults With Classic 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
    
    hrp0094p1-8
  - Backdoor Pathway hormones and 11-oxygenated Androgens are elevated in Patients with 21-hydroxylase deficiency
    
    hrp0094p1-9
  - Glucose regulation in children with primary adrenal insufficiency: preliminary data.
    
    hrp0094p1-10
- Bone A
- - Bone and endocrine monitoring in boys with Duchenne Muscular Dystrophy
    
    hrp0094p1-11
  - Real-world clinical profiles of children with hypophosphatasia (HPP) from the Global HPP Registry
    
    hrp0094p1-12
  - Characterisation and phenotype-genotype associations of a large cohort of patients with pseudohypoparathyroidism type 1A and 1B
    
    hrp0094p1-13
  - Tumor induced osteomalacia, a rare and complex condition with more treatment options, exemplified in two patients.
    
    hrp0094p1-14
  - Vitamin D status and guidelines in Paediatric Inflammatory Multisystem Syndrome Temporarily associated with SARS-CoV-2 (PIMS-TS)
    
    hrp0094p1-15
  - Leptin to adiponectin ratio at the age of 12 is negatively associated with lumbar spine bone mineral apparent density independently of body fat mass in 18-year old males.
    
    hrp0094p1-16
  - Clinical Spectrum of Hypomagnesemia type 1 (HOMG1) due to Novel TRPM6 mutations
    
    hrp0094p1-17
  - A rare cause of hypercalcemia: Congenital Lactase Deficiency
    
    hrp0094p1-18
  - Acetazolamide treatment in a patient with pseudohypoparathyroidism with venous calcification
    
    hrp0094p1-19
  - A novel TRPM6 variant (c.3179T>A) causing familial hypomagnesemia with secondary hypocalcemia
    
    hrp0094p1-20
- Diabetes A
- - Incidence of Type 1 Diabetes in Children and Adolescents during the Covid-19 Pandemic in Germany: Results from the DPV registry
    
    hrp0094p1-21
  - Early meal reporting enhances post-prandial glycaemic balance but remains underused in teenagers with artificial pancreas
    
    hrp0094p1-22
  - Capillary blood sample collection at home for HbA1c measurements during the COVID-19 pandemic in children with diabetes mellitus
    
    hrp0094p1-23
  - Resolution of feeding problems in patients with congenital hyperinsulinism
    
    hrp0094p1-24
  - Longitudinal Auxological Recovery and Reduced Neurodevelopmental Problems in Hyperinsulinaemic Hypoglycaemia
    
    hrp0094p1-25
  - Efficacy and Tolerability of GLP-1 Receptor Agonists in Children and Adolescents with Obesity
    
    hrp0094p1-26
  - The SARS-CoV-2 Pandemic Is Associated With Increased Severity Of Presentation Of Childhood Onset Type 1 Diabetes Mellitus: A Multicentre Study Of The First COVID-19 Wave
    
    hrp0094p1-27
  - Glycemic control and changes in habits in patients with type 1 diabetes during the lockdown due to the COVID-19 pandemic
    
    hrp0094p1-28
  - Incidence and severity of new-onset paediatric Type 1 diabetes in the COVID-19 pandemic - a UK multicentre perspective
    
    hrp0094p1-29
  - Metabolic Control and Health-Related Quality of Life in Children with Diabetes Mellitus during the COVID-19 Pandemic: Results from a Prospective Swiss Cohort Study
    
    hrp0094p1-30
- Fat, Metabolism and Obesity A
- - Efficacy and Safety of Setmelanotide in Individuals With Obesity Due to POMC or LEPR Deficiency: Phase 3 Results From Pivotal and Supplemental Cohorts
    
    hrp0094p1-31
  - Sex hormones drive changes in lipoprotein profiles in adolescents; early implications for cardiovascular disease risk
    
    hrp0094p1-32
  - Metabolomics in early life and the association with body composition at age 2 years
    
    hrp0094p1-33
  - High prevalence of undiagnosed metabolic dysfunction among children and adolescents with obesity in China
    
    hrp0094p1-34
  - The possible association of the apoptotic marker APO1/Fas with predisposition to metabolic syndrome and mean platelet volume in children
    
    hrp0094p1-35
  - Reversal of metabolic derangement in patient with congenital generalized lipodystrophy treated with metreleptin
    
    hrp0094p1-36
  - The effect of trans-palmitoleic acid on lipid accumulation and the fatty acid synthase gene expression in hepatocytes
    
    hrp0094p1-37
  - Are Serum Spexin Levels Associated With Metabolic Syndrome Antecedents In Obese Adolescents?
    
    hrp0094p1-38
  - Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
    
    hrp0094p1-39
  - Liraglutide for the Management of Childhood Obesity
    
    hrp0094p1-40
- Sex Endocrinology and Gonads A
- - Phenotypic Characteristics of Patients with 45,X/46,XY Mosaicism: Growth, Gonadal Pathology and Tumour Risk
    
    hrp0094p1-41
  - Disorders of sex development: clinical and genetic heterogeneity
    
    hrp0094p1-42
  - Broad range of phenotypes in an international cohort of 75 DSD individuals with SF-1/NR5A1 variants
    
    hrp0094p1-43
  - Adolescents and young adult men with non-syndromic hypospadias: testicular function and in-depth genetic screening
    
    hrp0094p1-44
  - Bilateral testicular regression: genetic etiology and outcome in a large Belgian series
    
    hrp0094p1-45
  - Endocrine & Molecular Genetic Findings In XY Boys Investigated For A Disorder Of Sex Development: the Glasgow Experience
    
    hrp0094p1-46
  - STK11 gene variant (Peutz-Jeghers Syndrome) presenting with unilateral pre-pubertal gynaecomastia and macro-orchidism without muco-cutaneous pigmentation or gastrointestinal symptoms.
    
    hrp0094p1-47
  - Gonadal Outcome in 17beta-HSD deficiency and 5alpha-reductase deficiency
    
    hrp0094p1-48
  - Biallelic PPP2R3C mutations are associated with partial and complete gonadal dysgenesis in 46,XY and 46,XX individuals
    
    hrp0094p1-49
  - Pathogenic variants in the human m⁶A reader YTHDC2 are associated with primary ovarian insufficiency
    
    hrp0094p1-50
- Bone B
- - A Global Natural History Study (NHS) of Fibrodysplasia Ossificans Progressiva (FOP): Normal Long Bone Growth and Abnormalities in Younger Patients over 36 Months
    
    hrp0094p1-51
  - Impact of Vertebral Fracture on Auxological Profile and Insulin-like Growth Factors of Children after Acute Lymphoblastic Leukemia Treatment
    
    hrp0094p1-52
  - Growth and Puberty in Patients with Osteogenesis Imperfecta
    
    hrp0094p1-53
  - Decreased bone mineral density in children receiving long-term anticoagulation is associated with pubertal development
    
    hrp0094p1-54
  - Premature epiphyseal fusion induced by a retinoic acid agonist in a young girl with fibrodysplasia ossificans progressiva
    
    hrp0094p1-55
  - Chondrocyte regulating and other growth plate genes are invaluable growth regulators: a study on children with short stature from 55 consanguineous families
    
    hrp0094p1-56
  - High rate of positive genetic findings in children born small for gestational age with persistent short stature (SGA-SS): Growth plate genes as key regulators of intrauterine growth
    
    hrp0094p1-57
  - AAV liver gene therapy-mediated inhibition of FGF23 signaling as a therapeutic strategy for X-linked hypophosphatemia
    
    hrp0094p1-58
  - Cartilage -specific knockout of SIRT1 significantly reduces bone quality and catch-up growth efficiency
    
    hrp0094p1-59
  - Mosaic PHEX variants are important causes of X-linked hypophosphataemic rickets.
    
    hrp0094p1-60
- Diabetes B
- - Timing of Hypoglycaemia in Patients with Hyperinsulinism (HI): Extension of the Digital Phenotype
    
    hrp0094p1-61
  - Epidemiology of type 1 diabetes in children and adolescents: a 50-year, single center experience
    
    hrp0094p1-62
  - Comparison of triglyceride and glucose index and homeostatic model assessment for insulin resistance in children and adolescents with type 2 diabetes mellitus
    
    hrp0094p1-63
  - Initial Neutrophil/Lymphocyte and Lymphocyte/Monocyte Ratios Can Predict Future Insulin Need in Newly Diagnosed Type 1 Diabetes Mellitus
    
    hrp0094p1-64
  - Efficacy of Use of Continuous Glucose Monitoring System in patients with Congenital Hyperinsulinism
    
    hrp0094p1-65
  - Mortality in children with monogenic diabetes
    
    hrp0094p1-66
  - The Molecular Genetic Etiology by Whole Exome Sequence Analysis in Cases With Familial Type 1 Diabetes Mellitus without HLA Haplotype Predisposition or Incomplete Predisposition
    
    hrp0094p1-67
  - Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11
    
    hrp0094p1-68
  - Oxidized lipid-associated protein damage in children and adolescents with type 1 diabetes mellitus: new diagnostic/prognostic clinical markers.
    
    hrp0094p1-69
  - Change in HbA1C predicts future abnormal Oral Glucose Tolerance Tests in children and adolescents with Cystic Fibrosis.
    
    hrp0094p1-70
- Fetal Endocrinology and Multisystem Disorders A
- - Morning salivary cortisol and stress response in term and preterm infants hospitalized in the intensive care unit.
    
    hrp0094p1-71
  - Clinical characteristics of children with Congenital Hyperinsulinism: Results from the European Registries for Rare Endocrine Conditions (EuRRECa) Project
    
    hrp0094p1-72
  - Minipuberty in born small for gestational age infants: a case control prospective pilot study
    
    hrp0094p1-73
  - Pancreatic glucagon-like-peptide-1 receptor expression in congenital hyperinsulinism
    
    hrp0094p1-74
  - Congenital hyperinsulinism diagnosed after 12 months can have a monogenic aetiology
    
    hrp0094p1-75
  - Hyperinsulinemic Hypoglycemia in a child with Peroxisomal Biogenesis Disorder due to a Novel PEX1 mutation
    
    hrp0094p1-76
  - Real-Time Continuous Glucose Monitoring in the Management of Neonates with Persistent Hypoglycemia
    
    hrp0094p1-77
  - Hyperinsulinemic hypoglycemia due to biallelic mutations in the DNAJC3 gene
    
    hrp0094p1-78
  - Concurrent hyperinsulinism and hypopituitarism in a 22 month old child due to a novel FOXA2 mutation
    
    hrp0094p1-79
  - Sphingosine 1- phosphate lyase insufficiency syndrome (SPLIS) as a cause of primary adrenal insufficiency and primary hypogonadism
    
    hrp0094p1-80
- Pituitary A
- - Sporadic pituitary adenomas in young patients: clinical and molecular description
    
    hrp0094p1-81
  - Cardiac remodeling in patients with childhood-onset craniopharyngioma - Results of HIT-Endo and KRANIOPHARYNGEOM 2000/2007
    
    hrp0094p1-82
  - Pregnancies after childhood craniopharyngioma - Results of Kraniopharyngeom 2000/2007
    
    hrp0094p1-83
  - Pituitary Duplication - A rare and heterogenous spectrum
    
    hrp0094p1-84
  - Auxological and endocrine aspects in pediatric patients with type 1 Narcolepsy. Results of long-term follow-up in a pediatric endocrinology center
    
    hrp0094p1-85
  - Adding a protease inhibitor to sampling tubes increases the acylated ghrelin and decreases the desacylated ghrelin levels in girls.
    
    hrp0094p1-86
  - GHSR protects the emergence of limited sex differences in anxiety-related behaviors in adult mice after long term THC administration during peri-adolescence
    
    hrp0094p1-87
  - Pituitary microadenomas in childhood - is follow-up with diagnostic imaging necessary?
    
    hrp0094p1-88
  - The Pituitary Tumour Module: Developing a Condition Specific Module within the European Registries for Rare Endocrine Conditions (EuRRECa)
    
    hrp0094p1-89
  - Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007
    
    hrp0094p1-90
- Thyroid A
- - The effect of preoperative calcitriol prophylaxis on post-thyroidectomy hypocalcaemia in children
    
    hrp0094p1-91
  - Emotional Intelligence scores in children and adolescents with subclinical hypothyroidism - correlation with serum serotonin and thyroid stimulating hormone (TSH) concentrations.
    
    hrp0094p1-92
  - "Lympocyte population in children and adolescents affected by Graves’ disease. Potential predictive tool of disease severity"
    
    hrp0094p1-93
  - Evaluation of children with intrathyroidal ectopic thymus
    
    hrp0094p1-94
  - Prevalence and Characteristics of thyroid nodules in a pediatric population with congenital hypothyroidism
    
    hrp0094p1-95
  - Thyroid storm and transient bulbar myopathy in a 22-month-old girl with Graves’ Disease
    
    hrp0094p1-96
  - The association between serum Thyrotropin within the reference range and cardiometabolic risk in obese children
    
    hrp0094p1-97
  - Hypothyroid Screening in Children with Down Syndrome - A Service Evaluation
    
    hrp0094p1-98
  - Early adiposity rebound in children with congenital hypothyroidism diagnosed by newborn screening
    
    hrp0094p1-99
  - Serum fibroblast growth factor 21 (FGF-21) levels of children and adolescents with Hashimoto’s thyroiditis, before and after L-thyroxin medication
    
    hrp0094p1-100
- Adrenal B
- - The management of adrenal cell carcinoma in a single tertiary centre: 25 year experience
    
    hrp0094p1-101
  - Correlation of 11-oxygenated C19 androgens with the clinical and biochemical characteristics in premature adrenarche
    
    hrp0094p1-102
  - Leukocyte telomere length in children with Congenital Adrenal Hyperplasia
    
    hrp0094p1-103
  - [rdquo]Cortison-loop[rdquo] is an educational tool, which helps ensure the quality of care for children with adrenal insufficiency.
    
    hrp0094p1-104
  - The genetic etiology of ACTH-dependent aldosterone hypersecretion in hypertensive patients without Primary Aldosteronism
    
    hrp0094p1-105
  - Plasma Proteomics in Healthy Subjects with Differences in Tissue Glucocorticoid Sensitivity Identifies a Novel Proteomic Signature
    
    hrp0094p1-106
  - Cortoic Acids: Renaissance of a Forgotten Class of Steroids
    
    hrp0094p1-107
  - Circadian rhythm of cortisol in saliva in obese children with clinical signs of hypercortisolism
    
    hrp0094p1-108
  - Plasma steroid panel with liquid chromotography-mass spectrometry (LC/MS-MS) method: utilization in differential diagnosis of hyperandrogenism
    
    hrp0094p1-109
  - Current Management Of Acute Adrenal Insufficiency Related Adverse Events In Children- Results Of An International Survey Of Specialist Centres
    
    hrp0094p1-110
- Fat, Metabolism and Obesity B
- - Insulin resistance following childhood craniopharyngioma may influence neural response to food cues in food reward-related brain regions: a preliminary investigation.
    
    hrp0094p1-111
  - Evaluation of the BigO behavioral indicators in overweight and obese children and adolescents
    
    hrp0094p1-112
  - Are you considering Idiopathic Intracranial Hypertension when evaluating a patient with obesity?
    
    hrp0094p1-113
  - EuRRECa Registry Genetic Obesity Survey Results
    
    hrp0094p1-114
  - Circulating C1q Complement/TNF-Related Protein (CTRP)-13 Levels in Obese Children and Its Relationship with Metabolic Disorders
    
    hrp0094p1-115
  - An Evidence-based Framework to Evaluate Melanocortin-4 Receptor (MC4R) Pathway Relevance for Obesity-associated Genes
    
    hrp0094p1-116
  - Serum Fibroblast Growth Factor 23 and Klotho concentrations in children and adolescents with obesity.
    
    hrp0094p1-117
  - Rare heterozygous variants in genes of the leptin-melanocortin satiety pathway contribute to childhood obesity
    
    hrp0094p1-118
  - Diagnostic precision of the Tri-Ponderal Mass Index (kg/m³) to identify the metabolic risk phenotype in obese children and adolescents
    
    hrp0094p1-119
  - Monogenic obesity in children: focusing on SH2B1 deletion
    
    hrp0094p1-120
- Growth A
- - Higher rates of non-skeletal complications in achondroplasia compared to the general population: a UK matched cohort study using the CPRD database
    
    hrp0094p1-121
  - Short stature in Protein Arginine Methyltransferase 7 (PRMT7) mutations: first evidences of growth response to rGH treatment
    
    hrp0094p1-122
  - Growth and nutrition improvement with recombinant growth hormone in prepubertal patients with Silver-Russell syndrome
    
    hrp0094p1-123
  - Management of endocrine aspects of Noonan syndrome across Europe: A subanalysis of a European clinical practice survey
    
    hrp0094p1-124
  - PROPEL2: a phase 2, open-label, dose-escalation and dose-expansion study of infigratinib in children with achondroplasia (ACH)
    
    hrp0094p1-125
  - Identification and tissue-specific characterization of novel SHOX-regulated genes in zebrafish highlights SOX family members among other genes
    
    hrp0094p1-126
  - Evaluation of early puberty in boys and girls with Silver-Russell Syndrome: Discordance between testicular growth and pituitary-gonadal hormones in male cases
    
    hrp0094p1-127
  - Evaluation of Persistent Short Stature in Children Born Small for Gestational Age without Catch-up Growth
    
    hrp0094p1-128
  - Computer-aided facial analysis as a tool to identify patients with Silver-Russell syndrome and Prader-Willi syndrome
    
    hrp0094p1-129
  - Study design and baseline characteristics of children enrolled in PROPEL: A prospective clinical assessment study in children with achondroplasia (ACH)
    
    hrp0094p1-130
- Growth Hormone and IGFs A
- - ABSTRACT WITHDRAWN
    
    hrp0094p1-131
  - Use of growth hormone therapy in short patients born small for gestational age: data from real-life French clinical practice
    
    hrp0094p1-132
  - Efficacy and safety profile of recombinant insulin like growth factor 1 (rh IGF1) therapy: A long term follow up study at a single tertiary centre.
    
    hrp0094p1-133
  - Starting recombinant human growth hormone treatment at an early age improves adherence and catch-up growth in patients with growth disorders, and highlights the importance of the new guideline on referral of short children to paediatric care
    
    hrp0094p1-134
  - Long-term safety of growth hormone in adults and adolescents with growth hormone deficiency: An overview of the full-cohort in KIMS
    
    hrp0094p1-135
  - Comparison of actual GH dose with labeled dose in children with short stature based on the LG Growth Study
    
    hrp0094p1-136
  - Persistently increased IGF-I levels and excellent auxological response despite low doses of recombinant growth hormone in a GH-deficient patient with a heterozygous variant of the growth hormone receptor (GHR) gene
    
    hrp0094p1-137
  - Safety and effectiveness of pediatric growth hormone therapy: Results from the full cohort in KIGS
    
    hrp0094p1-138
  - The effect of growth hormone therapy on linear growth and weight gain in children with growth hormone deficiency vs idiopathic short stature (ISS) a controlled study
    
    hrp0094p1-139
  - Linear growth response top Growth hormone therapy in underweight versus normal-weight children with idiopathic short stature (ISS).
    
    hrp0094p1-140
- Sex Endocrinology and Gonads B
- - Screening of serum differential proteins in girls with rapidly progressing central precocious puberty with TMT quantitative proteomics
    
    hrp0094p1-141
  - Investigation of primary adrenal insufficiency (PAI) in children with 46,XY differences in sex development (DSD)
    
    hrp0094p1-142
  - Current clinical practice of prenatal dexamethasone treatment in at risk pregnancies for classic 21 hydroxylase deficiency in Europe
    
    hrp0094p1-143
  - Ovarian AMH production is transiently affected in pubertal and prepubertal girls with acute lymphoblastic leukaemia and non-Hodgkin lymphoma receiving chemotherapy: a prospective, longitudinal study
    
    hrp0094p1-144
  - Serum anti-Mullerian hormone as a marker of ovarian reserve among childhood cancer survivors
    
    hrp0094p1-145
  - Reaching a definitive diagnosis of hypogonadotropic hypogonadism - experience of a multidisciplinary diagnostic service
    
    hrp0094p1-146
  - A pre-analytical challenge to determine estradiol in children: A monovette systematically causing increased estradiol-concentrations in LC-MS/MS analysis
    
    hrp0094p1-147
  - Central precocious puberty and sleep patterns in COVID-19 outbreak
    
    hrp0094p1-148
  - QUERY by TELARQUIA: Has there been an increase due to the SARS-COV19 pandemic?
    
    hrp0094p1-149
  - Androgen insensitivity without an androgen receptor mutation: results from a large cohort study
    
    hrp0094p1-150
- Fetal Endocrinology and Multisystem Disorders B
- - Duration of Fasting Studies Required to Demonstrate a Cure for Patients with Focal Congenital Hyperinsulinism.
    
    hrp0094p1-151
  - Impact of gestational weight gain on methylation of imprinted genes in umbilical cord and its relationship with postnatal growth and metabolism
    
    hrp0094p1-152
  - Different faces of minipuberty in preterm twin girls
    
    hrp0094p1-153
  - The Evaluation of Accuracy and Effectiveness of Newborn Screening for Congenital Adrenal Hyperplasia in Lithuania
    
    hrp0094p1-154
  - Pediatric Inflammatory Multisystemic Syndrome in Brazil: sociodemographic characteristics and risk factors to death
    
    hrp0094p1-155
  - Molecular and phenotypic profile of Alstrom syndrome in Chinese patients：results from a Chinese cohort
    
    hrp0094p1-156
  - Endocrine Monitoring and Outcome After Therapy In Childhood Survivors of Central Nervous System Tumours
    
    hrp0094p1-157
  - Low adrenal androgen levels in patients with and without primary adrenal insufficiency in APECED (APS1)
    
    hrp0094p1-158
  - Clinical features and body mineral density in Italian patients with rapid onset obesity with hypoventilation, hypothalamic dysfunction, autonomic disregulation and neural tumor (ROHHADNET): a single center observational study
    
    hrp0094p1-159
  - Congenital Central Hypothyroidism (CeH) due to a new variant in IGSF1 gene: clinical case of 2 siblings
    
    hrp0094p1-160
- Growth B
- - Continued Safety and Efficacy of Weekly Lonapegsomatropin (TransCon hGH) for up to Two Years in Children with Growth Hormone Deficiency (GHD)
    
    hrp0094p1-161
  - Evaluation of growth patterns from the Edinburgh and Gothenburg cohorts by the QEPS model
    
    hrp0094p1-162
  - The etiology of extreme tall stature above +3 SDS in a screened Finnish population
    
    hrp0094p1-163
  - Long-term efficacy and safety of rhGH in children with SHOX deficiency: preliminary data of a national Italian survey (on behalf of ISPED Study Group on Growth Factors and Puberty).
    
    hrp0094p1-164
  - Effects of age of start growth hormone treatment in children with Prader-Willi syndrome: The earlier the better?
    
    hrp0094p1-165
  - The BoneXpert adult height prediction method outperforms the Bayley and Pinneau method in tall male adolescents.
    
    hrp0094p1-166
  - Sex differences in growth response to GH treatment: more prepubertal and less pubertal gain in girls diagnosed with IGHD, ISS, SGA. Analysis of data from GH-SAFETY-database, including all children treated with rhGH- 1986-2009 in Sweden, in National-GH-Registry and rhGH-clinical-trials.
    
    hrp0094p1-167
  - Mother’s smoking during pregnancy influence intrauterine and postnatal growth - the GrowUp 1990 Gothenburg cohort population
    
    hrp0094p1-168
  - Safety of growth hormone and cardiovascular outcomes in patients with Noonan syndrome enrolled in NordiNet® International Outcome Study (IOS) and the ANSWER Program
    
    hrp0094p1-169
  - Facilitating Telehealth In A Tertiary Paediatric Endocrine Service: A Quality Improvement Initiative To Reduce The Discrepancy Between Parent-reported And Auxologist Height Measurements
    
    hrp0094p1-170
- Growth Hormone and IGFs B
- - Diagnosing growth hormone deficiency - Can a combined arginine and clonidine stimulation test replace two separate tests?
    
    hrp0094p1-171
  - Glucagon Testing of Childhood-Onset Growth Hormone Deficiency during Transition
    
    hrp0094p1-172
  - Growth hormone receptor 6Ω pseudoexon activation: a novel cause of severe growth hormone insensitivity
    
    hrp0094p1-173
  - High incidence and male predominance of transient form of isolated growth hormone (GH) deficiency in children. What is the optimal time for GH therapy withdrawal and retesting?
    
    hrp0094p1-174
  - Growth without growth hormone. A tertiary care hospital’s experience
    
    hrp0094p1-175
  - Irisin in the growth hormone deficient children: before and on rhGH therapy.
    
    hrp0094p1-176
  - Immunogenicity of recombinant growth hormone and relationship its growth-promoting effect in the children with short stature
    
    hrp0094p1-177
  - Study on linear growth of children with idiopathic short children (ISS) with Low Insulin-like growth factor 1 (IGFI) at diagnosis: Growth hormone (GH) treatment versus no treatment.
    
    hrp0094p1-178
  - Novel dominant negative GH receptor variants provide important insights into GH receptor physiology
    
    hrp0094p1-179
  - The miRNA network and the interplay between growth and cancer regulating pathways in prepubertal patients with idiopathic isolated growth hormone deficiency (IGHD) on growth hormone (GH) treatment
    
    hrp0094p1-180
- Pituitary B
- - Continuous versus discontinuous administration of gonadotropin in neonates with congenital hypogonadotropic hypogonadism
    
    hrp0094p1-181
  - Sequence of MKRN3 and DLK1 genes in cases with familial central precocious puberty
    
    hrp0094p1-182
  - Hypoandrogenism degree and lipid profile in boys with delayed puberty
    
    hrp0094p1-183
  - The pituitary gonadal axis is not responsive to GnRH administration in PCSK 1 dysfunction
    
    hrp0094p1-184
  - Puberty and pituitary-gonadal axis function after treatment for a childhood brain tumor
    
    hrp0094p1-185
  - Additive effect of androgens and estrogens on pubertal growth acceleration
    
    hrp0094p1-186
  - The Adrenal Steroid Profile in Adolescent Depression: A Valuable Bio-Readout?
    
    hrp0094p1-187
  - Congenital hypogonadotropic hypogonadism in a large French cohort : New genetic findings
    
    hrp0094p1-188
  - Dimensional changes in structures of craniofacial and brain in precocious puberty: Developmental surrogate markers of the brain as a secondary sex characteristic in puberty
    
    hrp0094p1-189
  - Six novel variants in the MKRN3 gene causing central precocious puberty: characteristics of ten patients and their affected relatives
    
    hrp0094p1-190
- Thyroid B
- - The Impact of Hospital Surgical Volume on Healthcare Utilisation Outcomes after Paediatric Thyroidectomy
    
    hrp0094p1-191
  - Analysis of hypothyroidism NGS test in Korean patients with congenital hypothyroidism in a single center
    
    hrp0094p1-192
  - Further evidence that Borealin/CDCA8 is involved in thyroid morphogenesis and aging
    
    hrp0094p1-193
  - Role of Next Generation Sequencing in the etiological diagnosis of congenital hypothyroidism with gland in situ
    
    hrp0094p1-194
  - DNA Methylation at a nutritionally sensitive region of the PAX8 gene is associated with thyroid volume and function in Gambian children
    
    hrp0094p1-195
  - Clinical and Molecular Presentation of Congenital Hypothyroidism Caused by Thyroglobulin Gene Mutations
    
    hrp0094p1-196
  - Management of newborns born to mothers with autoimmune hypothyroidism
    
    hrp0094p1-197
  - Novel single nucleotide variation in DUOX2 and NPTX1 genes in two Sardinian sisters with transient congenital hypothyroidism
    
    hrp0094p1-198
  - New p.Ser237Asn Activating Mutation At The TSHR Receptor, Causing Familial Non- Autoimmune Hyperthyroidism
    
    hrp0094p1-199
  - Functional studies of PAX8 gene variants in patients affected by congenital hypothyroidism with eutopic thyroid gland
    
    hrp0094p1-200
ePoster Category 2
- Adrenals and HPA Axis
- - Circadian rhythm of salivary cortisol and cortisone in school-aged children born very preterm and adequate for gestational age
    
    hrp0094p2-1
  - How do urine steroid metabolites of spot samples correlate with 24 hour urine specimens in children with congenital adrenal hyperplasia?
    
    hrp0094p2-2
  - Endocrine-disrupting chemicals: an often-forgotten etiology of endocrinological disturbances
    
    hrp0094p2-3
  - Serum Sex Hormone Binding Globulin Levels, But Not 4-Hour Profile of 17-Oh Progesterone, Would Be Useful in Monitoring Children with Congenital Adrenal Hyperplasia
    
    hrp0094p2-4
  - Glucocorticoid side-effects in Duchenne Muscular Dystrophy: Systematic review of side effects in published literature and a survey of the concerns of the patient community
    
    hrp0094p2-5
  - Single centre experience of Hydrocortisone Granules (Alkindi) in children under 6 years of age with Adrenal Insufficiency
    
    hrp0094p2-6
  - Emotion regulation in congenital adrenal hyperplasia
    
    hrp0094p2-7
  - High-dose steroids in the management of Paediatric Multisystem Inflammatory Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS): Considering the hypothalamic-pituitary-adrenal axis
    
    hrp0094p2-8
  - Variability of advice and education for steroid sick day dosing in Duchenne Muscular Dystrophy and the impact of the COVID-19 pandemic: Results of a UK wide patient survey
    
    hrp0094p2-9
  - Clinical characteristics of cytochrome P450 oxidoreductase deficiency: a nationwide survey in Japan
    
    hrp0094p2-10
  - Rare Presentation of Adrenal Insufficiency in an Infant with Holocarboxylase Synthetase Deficiency
    
    hrp0094p2-11
  - Defective Cortisol Secretion in Response to Spontaneous Hypoglycemia but Normal Cortisol Response to ACTH stimulation in neonates with Hyperinsulinemic Hypoglycemia (HH).
    
    hrp0094p2-12
  - Utilisation Of The I-CAH Registry As A Tool For Facilitating Health Quality Improvement Strategies- Results Of An International Survey Of Specialist Centres
    
    hrp0094p2-13
  - Clinical and hormonal evolution of aldosterone synthase deficiency: Is complete remission possible?
    
    hrp0094p2-14
  - Clinical and metabolic characteristics of hyperandrogenic girls with non-classic congenital adrenal hyperplasia and polycystic ovary syndrome
    
    hrp0094p2-15
  - Rapid clearance of hydrocortisone as a cause of poor control of CAH detected by 24-hour profiling of hydrocortisone concentrations.
    
    hrp0094p2-16
  - A prospective study of children 0-8 years with congenital adrenal hyperplasia and adrenal insufficiency on treatment with hydrocortisone granules monitored by 17-OHP saliva sampling
    
    hrp0094p2-17
  - Cushing’s disease treatment results correlation with pituitary MRI in children
    
    hrp0094p2-18
  - Genetic analysis of paediatric primary adrenal insufficiency of unknown aetiology over 25 years
    
    hrp0094p2-19
  - Panhypopituitarism after treatment procedures in pituitary-hypothalamic area - a single center experience
    
    hrp0094p2-20
  - The reliability of Salivary Cortisol compared to Serum Cortisol for diagnosing adrenal insufficiency in the gold standard ACTH stimulation test in children
    
    hrp0094p2-21
  - Prevalence of adrenal insufficiency (AI) requiring treatment with hydrocortisone in children tested with the LDSST
    
    hrp0094p2-22
  - Serum cortisol and cortisone, and urinary cortisol, cortisone, and tetrahydro-metabolites concentrations in school-aged children born very preterm adequate for gestational age
    
    hrp0094p2-23
  - The incidence and presentation of congenital adrenal hyperplasia in an unscreened population
    
    hrp0094p2-24
  - Genotypic Sex and Severity of the Disease Determine the Time of Clinical Presentation in Steroid 17[alpha]-Hydroxylase/17,20-Lyase Deficiency
    
    hrp0094p2-25
  - Testicular adrenal rest tumour in children with classical congenital adrenal hyperplasia: A case series.
    
    hrp0094p2-26
  - High doses op’-DDD cause metrorragia in young girls
    
    hrp0094p2-27
  - An Adolescent Case With Adrenoleukodystrophy Diagnosed After Detection Of Leydig Cell Dysfunction
    
    hrp0094p2-28
  - Fludrocortisone is the salvage treatment in cases with calcineurin inhibitor related hyperkalemia
    
    hrp0094p2-29
  - Development of a novel weight-based steroid emergency plan for patients with Duchenne Muscular Dystrophy
    
    hrp0094p2-30
  - Investigation of usage and acceptance of hydrocortisone granules in capsules for opening in children with adrenal insufficiency
    
    hrp0094p2-31
  - Congenital Adrenal Hyperplasia caused by homozygous pathogenic variant in the HSD3B2 gene.
    
    hrp0094p2-32
  - Congenital Adrenal Hyperplasia with a CYP21A2 deletion overlapping Tenascin-X gene
    
    hrp0094p2-33
  - Maternal primary adrenal cortex insufficiency during pregnancy: Spotlight on the Fetus and the Neonate. A systematic review and meta-analysis.
    
    hrp0094p2-34
  - Assessment of blood pressure and carotid intima media thickness (CIMT) in children with primary adrenal insufficiency
    
    hrp0094p2-35
  - Challenging in diagnosis and treatment of Cushing Disease in a 12 years old boy
    
    hrp0094p2-36
  - Congenital Adrenal Hyperplasia caused by compound heterozygosity of two novel CYP11B1gene variants.
    
    hrp0094p2-37
  - Addison’s disease: Delay in diagnosis in a girl with longstanding symptoms
    
    hrp0094p2-38
  - Clinical spectrum of congenital adrenal hyperplasia due to 3 beta hydroxysteroid dehydrogenase deficiency; A case series
    
    hrp0094p2-39
  - Retrospective Evaluation of Cases Diagnosed with Classical Congenital Adrenal Hyperplasia Due to 21 Hydroxylase Deficiency
    
    hrp0094p2-40
  - Corticotropin-independent Cushing’s Syndrome in toddlerhood: a challenging diagnosis and treatment
    
    hrp0094p2-41
  - A case of adrenal insufficiency during the course of multisystem inflammatory syndrome in children (MIS-C)
    
    hrp0094p2-42
  - Aetiology and different clinical conditions of primary adrenal insuffiency in a region of North Africa
    
    hrp0094p2-43
  - Clinical and evolutionary aspects of Allgrove Syndrome, Algerian experience
    
    hrp0094p2-44
  - A Rare Coexistence of two autosomal recessive conditions: Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (CYP21A2 mutation) with Beta Thalassemia Major
    
    hrp0094p2-45
  - X-linked Adrenoleukodystrophy in south of Tunisia
    
    hrp0094p2-46
  - Clinical, biological and genetic aspects of congenital adrenal hyperplasia in children at the Central Army Hospital in Algiers
    
    hrp0094p2-47
  - Coexistence of Adrenal Insufficiency and Hypergonadotropic Hypogonadism: P450scc Deficiency
    
    hrp0094p2-48
  - Assessment of Patients With Congenital Adrenal Hyperplasia in Armenia
    
    hrp0094p2-49
  - First case in Lebanon of homozygous mutation in CYP 11B2 leading to isolated aldosterone deficiency.
    
    hrp0094p2-50
  - A Rare Cause of Hyponatremia in a Child with Hirschsprung Disease Operated with an Ileostomy
    
    hrp0094p2-51
  - Adrenal insufficiency masquerading as biliary atresia in an infant
    
    hrp0094p2-52
  - Mutation of NROB1 and Double mutants in cis of CYP21A2 gene in a Chinese boy with primary adrenal insufficiency
    
    hrp0094p2-53
  - Clinical and hormonal features of the manifestation of various forms of congenital adrenal hyperplasia in children in real clinical practice
    
    hrp0094p2-54
  - Twin infants with salt-wasting: double the trouble
    
    hrp0094p2-55
  - Effect of treatment of double precocious puberty in a 9-year-old girl- case report
    
    hrp0094p2-56
  - Classical Congenital adrenal hyperplasia: about 7 cases
    
    hrp0094p2-57
- Bone, growth plate and mineral metabolism
- - Denosumab therapy for giant cell granuloma in a paediatric patient: using quantification of Tc99m-MDP uptake on SPECT imaging to guide treatment.
    
    hrp0094p2-58
  - Vertebral compression and shape in children with osteogenesis imperfecta on regular Zoledronic acid infusions
    
    hrp0094p2-59
  - Osteosclerotic Metaphyseal Dysplasia: A novel homozygous LRRK1 mutation in two siblings
    
    hrp0094p2-60
  - Experience of 6-months of burosumab therapy in five siblings with X-linked hypophosphataemic rickets in the State of Kuwait
    
    hrp0094p2-61
  - Severe Hypophosphatemic Rickets due to Tumor-Induced Osteomalasia
    
    hrp0094p2-62
  - Diagnostic Challenges of Vitamin D-Dependent Rickets Type 1A (VDDR1A) caused by CYP27B1 mutation in Resource Limited Countries: A Case Series from Three families
    
    hrp0094p2-63
  - Lack of Cinacalcet response in Neonatal Severe Hyperparathyroidism (NSHPT) due to homozygous CASR mutation
    
    hrp0094p2-64
  - Is conventional treatment still the first choice in pediatric patients with PHEX mutations in an era of monoclonal FGF-23 antibody?
    
    hrp0094p2-65
  - Vosoritide Clinical Study Data Demonstrates CXM is a Superior Biomarker of Endochondral Bone Growth
    
    hrp0094p2-66
  - X-linked hypophosphatemic rickets caused by a large deletion in PHEX gene in a Brazilian family
    
    hrp0094p2-67
  - Mutational analysis and genotype-phenotype correlation of the PHEX gene in Brazilian patients with X-linked hypophosphatemic rickets
    
    hrp0094p2-68
  - Evaluation of Admission Characteristics, Treatment and Follow-up Findings of Children with Primary Osteoporosis
    
    hrp0094p2-69
  - Phenotype characterization of a PHEX intron mutation in an Italian family affected by X linked hypoposphatemic rickets.
    
    hrp0094p2-70
  - Premature epiphyseal fusion induced by Palovarotene in a young girl with fibrodysplasia ossificans progressiva
    
    hrp0094p2-71
  - ACAN gene skeletal dysplasia (short size syndrome, with or without advanced bone age and early onset osteoarthritis)
    
    hrp0094p2-72
  - PTEN downregulation in mouse osteoprogenitor cells impacts on bone stability and turnover
    
    hrp0094p2-73
  - Primary hyperparathyroidism due to a deletion of the CDC73 gene.
    
    hrp0094p2-74
  - Afebrile seizure in a toddler girl with alopecia: a case report
    
    hrp0094p2-75
  - A rare cause of hypophosphatemic rickets; Non-lethal Raine syndrome
    
    hrp0094p2-76
  - Effect of tamoxifen on linear growth of precocious female SD rats
    
    hrp0094p2-77
  - Deleting STX16 exon 4 to understand the genetic mechanisms underlying pseudohypoparathyroidism-1B and GNAS imprinting
    
    hrp0094p2-78
  - Clinical, molecular characterization and long-term follow-up of a patient with neonatal severe hyperparathyroidism
    
    hrp0094p2-79
  - Effect of Soy and Whey on growth pattern in young male Sprague-Dawley rats
    
    hrp0094p2-80
  - Early-onset osteoporosis due to LRP5
    
    hrp0094p2-81
  - Vitamin D - What is the Optimal Level in the Pediatric Population
    
    hrp0094p2-82
  - Schimke immune-osseous dysplasia manifested by stunted growth and spinal epiphyseal dysplasia: a case report
    
    hrp0094p2-83
  - A rare cause of childhood hypercalcemia: Parathyroid adenoma
    
    hrp0094p2-84
  - One gene, two diseases: osteogenesis imperfecta, or Bruck syndrome?
    
    hrp0094p2-85
  - Spontaneous Reshaping of Vertebral Fractures in an Adolescent with Osteogenesis Imperfecta
    
    hrp0094p2-86
  - A rare presentation of Dysplasia Epiphysealis Hemimelica combined with Familial Hypocalciuric Hypercalcemia - Is this association possible?
    
    hrp0094p2-87
  - Two sibling cases with heterozygous calcium sensing receptor (CaSR) gene mutation
    
    hrp0094p2-88
  - Clinical Profile of Parathyroid Adenoma in Children and Adolescents: A single-center experience
    
    hrp0094p2-89
  - Changing reality: rebirth of old diseases in new circumstances. Severe vitamin D deficiency presenting as hypocalcemic seizures in a healthy adolescent after prolonged COVID-19 lock-down.
    
    hrp0094p2-90
  - Two-year experience of burosumab therapy in pediatric XLH patients in Saudi Arabia
    
    hrp0094p2-91
  - Pseudohypoparathyroidism with hypokalemia and hypomagnesemia: association or separate entity?
    
    hrp0094p2-92
  - Characterization of Patients with Achondroplasia in a pediatric clinic of Cali, Colombia.
    
    hrp0094p2-93
  - A Rare Cause of Familial Hypomagnesemia: A Case with Trpm6 Mutation
    
    hrp0094p2-94
  - Effect of cholecalciferol treatment on serum FGF-23, vitamin D-binding globulin and [alpha]-klotho levels in children with vitamin D deficiency
    
    hrp0094p2-95
  - HDR Syndrome (Barakat Syndrome): Case Report
    
    hrp0094p2-96
  - Hungry Bone Syndrome associated to Rickets
    
    hrp0094p2-97
  - BUR-CL207: An Open-label, Multicenter, Non-randomized Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Pediatric Patients from Birth to Less than 1 Year of Age with XLH.
    
    hrp0094p2-98
- Diabetes and insulin
- - Glycemic Dysregulation During Treatment Of Childhood Hematologic Malignancies.
    
    hrp0094p2-99
  - The knowledge and Confidence in Management of Diabetic Ketoacidosis (DKA) among Iraqi Paediatric Residents: a Cross Sectional Study
    
    hrp0094p2-100
  - Disturbances of glucose homeostasis in polytransfused beta-thalassemia patients
    
    hrp0094p2-101
  - Unmet need in technology for diabetes management in the Middle East, Africa and South East Asia
    
    hrp0094p2-102
  - Diabetes in a child with infantile onset multisystem neurological, endocrine and pancreatic disease (IMNEPD)
    
    hrp0094p2-103
  - The clinical characteristics of hybrid diabetes (HD) in children and their response to treatment.
    
    hrp0094p2-104
  - Recurrent episodes of hypoglycemia in an infant with type 1 spinal muscular atrophy after gene therapy: Beta oxidation defect exaggerated by hepatic dysfunction.
    
    hrp0094p2-105
  - Knowledge of the Final Year Medical Students Compared to Interns about the Diagnosis and management of Diabetes Mellitus
    
    hrp0094p2-106
  - A paradoxical conundrum: diabetic ketoacidosis resulting in treatment-resistant hypokalemic alkalosis
    
    hrp0094p2-107
  - Impact of the COVID19 pandemic on Paediatric Diabetes Services in Arab Countries
    
    hrp0094p2-108
  - Clinical Case of Cystic Fibrosis-like and APECED-like Syndrome due to Gain-of-Function Variant in STAT1
    
    hrp0094p2-109
  - A quality improvement project of a Young Adult Diabetes (YAD) service at a UK specialist centre.
    
    hrp0094p2-110
  - Prevalence of skin reactions among pediatrics patients with Type 1 Diabetes users of glucose sensors.
    
    hrp0094p2-111
  - A single-centre evaluation of remote video consultation for children and young people with diabetes
    
    hrp0094p2-112
  - Health Outcome Indicators in Children with Diabetes Mellitus during the SARS-CoV-2 Pandemic
    
    hrp0094p2-113
  - Evaluation of serum myostatin levels in patients with insulin dependent diabetes mellitus
    
    hrp0094p2-114
  - HbA1c and Glucose Management Indicator relationship: can HbA1c determination be avoided?
    
    hrp0094p2-115
  - Sex differences over two decades for glycaemic control, pump use and insulin dose in patients aged 10-20 years with type 1 diabetes
    
    hrp0094p2-116
  - Cardiovascular risk factors in adolescents with type 1 diabetes: Prevalence and gender differences
    
    hrp0094p2-117
  - Bilateral severe proliferative retinopathy, macular oedema, and lack of macrocytosis in an adolescent male with thiamine-responsive megaloblastic anaemia
    
    hrp0094p2-118
  - First Survey About Pediatric Diabetes Services in Iraq
    
    hrp0094p2-119
  - Effect of metabolic control on the presence of Nonalcoholic Fatty Liver Disease (NAFLD) in adolescents with type 2 Diabetes.
    
    hrp0094p2-120
  - The effect of glycemic variability on DNA damage in pediatric patients with type 1 Diabetes Mellitus
    
    hrp0094p2-121
  - Parental insulin resistance is associated with unhealthy lifestyle behaviours independently of body mass index in children: The Feel4Diabetes study
    
    hrp0094p2-122
  - Use of the whole country insulin consumption data in Israel showed a reduced prevalence of type 1 diabetes in children aged <5 years during universal Rotavirus vaccination
    
    hrp0094p2-123
  - Psychological changes in youth with diabetes: comparison between preadolescents and adolescents
    
    hrp0094p2-124
  - Focal Congenital Hyperinsulinism in Infancy is Directly Linked to Increased Numbers of Islet Pancreatic Polypeptide Cells in Islets.
    
    hrp0094p2-125
  - Oral administration of CRN04777, a nonpeptide selective SST5 receptor agonist, suppresses insulin secretion and rescues hypoglycemia in neonatal rat models of congenital hyperinsulinism
    
    hrp0094p2-126
  - Thiamine-responsive megaloblastic anemia: a rare presentation of an uncommon disease!
    
    hrp0094p2-127
  - Daily Meal Size Variation Does Not Affect Glycemic Control In T1D Adolescent Patients Equipped With The Closed Loop DBLG1 System
    
    hrp0094p2-128
  - Evaluation of continuous glucose monitoring for the diagnosis of cystic fibrosis related diabetes (CFRD). A prospective and longitudinal study
    
    hrp0094p2-129
  - Blood lipid concentrations of newborns and their mothers with gestational diabetes
    
    hrp0094p2-130
  - Comparison between hybrid diabetes (HD) and type 2 diabetes (T2DM) in children; Patient`s characteristics at diagnosis: a retrospective observational study.
    
    hrp0094p2-131
  - Features of the manifestation of type 1 diabetes in children in COVID-19 pandemic
    
    hrp0094p2-132
  - Risk factors of autoimmune thyroid disease in children with type 1 diabetes mellitus
    
    hrp0094p2-133
  - Does SARS-COV-2 outbreak increase diabetic ketoacidosis in new onset T1DM
    
    hrp0094p2-134
  - Heterozygous mutation in the PAX4 gene: a first case description of MODY9 in Vietnam
    
    hrp0094p2-135
  - Evaluation of the Effect of Carbohydrate Count on Nutritional Habits and Metabolic Control in Adolescents with Type 1 Diabetes
    
    hrp0094p2-136
  - Nutritional evaluation of children with type 1 diabetes on admission to the Endocrinology-Diabetology and Nutrition Department
    
    hrp0094p2-137
  - Correlation between antiinsulin autoantibodies and clinical presentation in T1DM
    
    hrp0094p2-138
  - Different schemes of insulin therapy (CSII and MDII) in children with DM1 in a Dnipro city.
    
    hrp0094p2-139
  - HbA1c of T1DM Patients before and after Transition - Single Center Experience
    
    hrp0094p2-140
  - Glycated Hemoglobin Variability and Microvascular Complications in Patients with Type 1 Diabetes Mellitus
    
    hrp0094p2-141
  - Affective response of newly diagnosed Type1 diabetes parents: An experience of a developing country.
    
    hrp0094p2-142
  - Short-term glycaemic changes from continuous glucose monitoring among children and adolescents with type 1 diabetes mellitus during fasting in Ramadan month
    
    hrp0094p2-143
  - Is Type 1 Diabetes Mellitus Predictable? Investigation of Predictive Markers n Siblings of Probands with Newly Diagnosed Type 1 Diabetes Mellitus
    
    hrp0094p2-144
  - Dealing with hypoglycaemia during acute DKA management by paediatric residents from Bahrain, Iraq and Saudi Arabia
    
    hrp0094p2-145
  - A Rare Clinical Case Of A Combination Of Monogenic And Autoimmune Diabetes Mellitus.
    
    hrp0094p2-146
  - Thrombocytopaenia induced by diazoxide treatment in a toddler with Hyperinsulinism-Hyperammonemia syndrome: a rare side-effect
    
    hrp0094p2-147
  - Nephrotic Syndrome and Type 1 Diabetes: a Therapeutic Approach
    
    hrp0094p2-148
  - Assessment of the percentage of T lymphocytes and B lymphocytes with the expression of selected activation markers in patients with type 1 diabetes mellitus depending on the presence of antibodies against EBV antigens.
    
    hrp0094p2-149
  - PIMS-TS [Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (Covid-19)] in a child with new onset type 2 diabetes
    
    hrp0094p2-150
  - The impact of COVID-19 lockdown on glycaemic control and BMI in children with type 1 diabetes mellitus (T1DM)
    
    hrp0094p2-151
  - Timing of Consulting Paediatric Endocrinologist or Diabetologist During the Management of Acute DKA; Response of Bahraini, Iraqi, and Saudi Paediatric Residents
    
    hrp0094p2-152
  - Prevalence and factors associated with microalbuminuria in type 1 diabetic children and adolescents on follow up at Pediatric Endocrinology Clinic in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
    
    hrp0094p2-153
  - Neonatal Diabetes Secondary to Isolated Pancreatic Agenesis
    
    hrp0094p2-154
  - Dyslipidaemia in children with type 1 diabetes mellitus
    
    hrp0094p2-155
  - The relationship between metabolic parameters atherogenic parameters, atherogenic index and vitamin D levels in children with insulin-dependent diabetes mellitus
    
    hrp0094p2-156
  - A case of severe hypertriglyceridaemia complicating new-onset type 1 diabetes mellitus
    
    hrp0094p2-157
  - A novel variant HNF1A gene (HNF1A-MODY) in a patient presenting with hyperglycaemia and glycosuria
    
    hrp0094p2-158
  - Glucose 6 phosphate dehydrogenase deficiency diagnosed with hemolytic anemia triggered by diabetes mellitus type 1
    
    hrp0094p2-159
  - HbA1C stability - is posting samples reliable?
    
    hrp0094p2-160
  - Not every obese child has type 2 Diabetes Mellitus
    
    hrp0094p2-161
  - Does insulin pump therapy improve glycaemic control in type 1 diabetes children: one year follow up
    
    hrp0094p2-162
  - Mauriac syndrome: a complication that still exists in children with type 1 diabetes. Report of a case.
    
    hrp0094p2-163
  - The Impact of COVID 19 Pandemic on Type 1 Diabetes Mellitus: An experience of a Tertiary Care Hospital in a resource limited country
    
    hrp0094p2-164
  - Co-existence of new onset diabetic ketoacidosis with severe hypertriglyceridemia in a 9 year old girl.
    
    hrp0094p2-165
  - How Does Continuous Glucose Monitoring Systems Effect Metabolic Control In Type 1 Diabetes: Single Center Experience
    
    hrp0094p2-166
  - Blood level of Vitamin D and metabolic control of type 1 diabetes mellitus
    
    hrp0094p2-167
  - Newly-onset type 1 diabetes mellitus triggered by COVID-19: Original case report
    
    hrp0094p2-168
  - Case of HNF1B MODY
    
    hrp0094p2-169
  - Diabetes Ketoacidosis Recovery in Youth with Newly Diagnosed and Established Type 1 Diabetes
    
    hrp0094p2-170
- Fat, metabolism and obesity
- - Association of calprotectin with obesity in prepubertal children
    
    hrp0094p2-171
  - Metabolic syndrome and birth anthropometric data in Prader-Willi syndrome.
    
    hrp0094p2-172
  - Evaluation of the BigO system during the COVID-19 outbreak in Greece
    
    hrp0094p2-173
  - The relationship between sleep time and obesity in childhood
    
    hrp0094p2-174
  - The relationship between acanthosis nigricans and vitamin D in obese children and adolescents
    
    hrp0094p2-175
  - Exploring Urinary Bile Acids as Potential Markers of Metabolism: Reference Values in Children by Targeted LC-MS/MS
    
    hrp0094p2-176
  - A novel mitochondrial tRNA^Thr 15894G>A mutation is potentially risk factor in a Chinese family with obesity
    
    hrp0094p2-177
  - Obesity is potentially associated with a novel mitochondrial tRNA^Gly 10029A>G mutation in a Chinese family
    
    hrp0094p2-178
  - Frequency of MC4R Pathway Variants in a Large US Cohort of Pediatric and Adult Patients with Severe Obesity
    
    hrp0094p2-179
  - Impact of the COVID-19 pandemic and related lockdown measures on lifestyle behaviours and quality of life in children and adolescents with severe obesity
    
    hrp0094p2-180
  - Longitudinal association of the anti-inflammatory serum marker GDF-15 with serum IgA and IgG in apparently healthy children
    
    hrp0094p2-181
  - Describing the Natural History of Clinical, Biochemical and Radiological outcomes of children with Familial Partial Lipodystrophy type 2 (FPLD2) attending a National Service for Severe Insulin Resistance: a Retrospective Cohort Study
    
    hrp0094p2-182
  - Evaluation of the BigO system in a clinical setting in Greece
    
    hrp0094p2-183
  - Assessment of DRD2 dopamine receptor gene rs6277 in pediatric obesity: a case-control study
    
    hrp0094p2-184
  - A Comprehensive, Multidisciplinary, Personalized, Lifestyle Intervention Program is Associated with Increased Leukocyte Telomere Length in Children and Adolescents with Overweight and Obesity
    
    hrp0094p2-185
  - Diagnostic accuracy of Tri-Ponderal mass index (kg/m³) for identifying glucose intolerance in obese children and adolescents.
    
    hrp0094p2-186
  - Effect of Semaglutide on body weight in obese children with craniopharyngioma: a preliminary report
    
    hrp0094p2-187
  - Development of a predictive normogram to assess the risk of liver steatosis in childhood obesity
    
    hrp0094p2-188
  - Prospective evaluation of liver stiffness in obese children: the role of shear wave elastography.
    
    hrp0094p2-189
  - Evaluation of the nutritional behavior of small and large for gestational age children
    
    hrp0094p2-190
  - Resting energy expenditure and body composition in children and adolescents with severe obesity due to (suspected) medical causes: comparison between different subtypes of obesity
    
    hrp0094p2-191
  - Exercise-induced expression of myokines in adolescents with simple obesity.
    
    hrp0094p2-192
  - Early decline in Sertoli cell function during puberty in overweight and obese boys: a cross-sectional study
    
    hrp0094p2-193
  - Vitamin D deficiency in obese children
    
    hrp0094p2-194
  - Assessment of Hyperphagia in Patients with Monogenic Obesity
    
    hrp0094p2-195
  - Machine Learning Quest for Predictive Markers of Lifestyle Modification Outcomes in Pediatric Obesity Treatment
    
    hrp0094p2-196
  - Triponderal mass index for the categorisation of childhood obesity on the basis of 58.364 observations of 7.792 patients
    
    hrp0094p2-197
  - Successful weight loss and resolution of hepatic fibrosis in a girl with severe obesity
    
    hrp0094p2-198
  - Association of Thyroid-Stimulating Hormone and Free Thyroxine Concentrations with Cardiometabolic Risk Factors in Euthyroid Obese Children and Adolescents with Metabolic Syndrome
    
    hrp0094p2-199
  - Impact of weight loss on gonadic function in overweight and obese boys
    
    hrp0094p2-200
  - Weight status and body composition of children and adolescents during the COVID-19 pandemic
    
    hrp0094p2-201
  - The challenges faced in the management of Congenital Generalized Lipodystrophy.
    
    hrp0094p2-202
  - Anthropometric and clinical situation in two groups of young adults born Small for Gestational Age (a group with catch-up and another without catch-up and treated with Growth Hormone)
    
    hrp0094p2-203
  - Changes in objectively measured physical activity after 2-year lifestyle intervention in pediatric patients with abdominal obesity
    
    hrp0094p2-204
  - Assessment of cardiometabolic risk factor clustering in obese children and adolescents with metabolic syndrome
    
    hrp0094p2-205
  - HOMA-IR in obese children with BMI ≥2.5SDS, but not <2.5SDS, differ significantly from normal weight children
    
    hrp0094p2-206
  - Restriction of physical activity is the main cause of childhood obesity during the COVID-19 pandemic - reflections from a study conducted in 3 clinical centers in southern Poland
    
    hrp0094p2-207
  - OSAS in childhood obesity is a more frequent and earlier complication than expected
    
    hrp0094p2-208
  - A novel homozygous variant of the leptin receptor (LEPR) gene causing familiar early-onset severe obesity in two siblings
    
    hrp0094p2-209
  - Sleep quality and metabolic syndrome in pediatric patients with abdominal obesity
    
    hrp0094p2-210
  - The lockdown effects on a pediatric obese population in the COVID-19 era
    
    hrp0094p2-211
  - The Relationship between Acanthosis Nigricans and Vitamin D Levels in Obese Children
    
    hrp0094p2-212
  - Influence of birth weight on cardiovascular risk factors in obese children and adolescents
    
    hrp0094p2-213
  - A study on the Complications associated with Severe Obesity in Children and Young People
    
    hrp0094p2-214
  - The Effectiveness of Indigenous Knowledge-Based Lifestyle Interventions in Preventing Obesity and Type 2 Diabetes Mellitus in Indigenous Children in Canada
    
    hrp0094p2-215
  - The effects of dextroamphetamine treatment in children with hypothalamic obesity
    
    hrp0094p2-216
  - Nutritional status in premature infants born small by gestational age in the first 5 years of life
    
    hrp0094p2-217
  - Impact of overweight and obesity in pediatrics. Metabolic syndrome and its components
    
    hrp0094p2-218
  - What do lipids tell us about the pandemic?
    
    hrp0094p2-219
  - Characteristics of eating behavior in children with type 1 diabetes and obesity
    
    hrp0094p2-220
  - [ldquo]Sleep Properly, Reduce Intake, aNd Get Stepping[rdquo] (SPRINGS): a multidisciplinary approach to managing paediatric morbid obesity with severe obstructive sleep apnoea
    
    hrp0094p2-221
  - Design of a Phase 2, Double-Blind, Placebo-Controlled Trial of Setmelanotide in Patients With Genetic Variants in the Melanocortin-4 Receptor Pathway
    
    hrp0094p2-222
  - Absence of dyslipidemia in obese children with BMI ≥2.5SDS and similar lipidemic profile to those with BMI <2.5SDS or normal weight
    
    hrp0094p2-223
  - Inflammation associated to body composition in European prepubertal children: Results from the IDEFICS study
    
    hrp0094p2-224
  - A case report of sitosterolemia and the early differential diagnosis
    
    hrp0094p2-225
  - Thyroid function in youth with metabolic syndrome
    
    hrp0094p2-226
  - Global survey study of awareness, care and treatment of adolescents living with obesity, their caregivers and healthcare professionals: ACTION Teens
    
    hrp0094p2-227
  - Lifestyle habits, consumption of non-nutritive sweeteners and obesity in students and young adults’ population in Latvia.
    
    hrp0094p2-228
  - Influence of the basal metabolic profile on the evolution of the pediatric patient with obesity
    
    hrp0094p2-229
- Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia)
- - The utility of continuous glucose monitoring systems in the management of children with persistent hypoglycaemia
    
    hrp0094p2-230
  - Hyperinsulinaemic hypoglycaemia as a MEHMO syndrome component: a case report
    
    hrp0094p2-231
  - Methylation of umbilical cord genes associates with gestational weight gain and offspring’s cardio-metabolic profile
    
    hrp0094p2-232
  - Diazoxide Responsive Congenital Hyperinsulinism
    
    hrp0094p2-233
  - Continuous Glucose Monitoring (CGM) Reveals Undertreated Hypoglycemia in Patients with Congenital Hyperinsulinism
    
    hrp0094p2-234
  - A Selective Nonpeptide Somatostatin Receptor 5 (SST5) Agonist Effectively Decreases Insulin Secretion in a KATPHI Mouse Model and in Human HI Islets
    
    hrp0094p2-235
  - Placental FRAT-1 methylation in women with gestational obesity is associated with the body composition in the offspring at 6 years of age
    
    hrp0094p2-236
  - Placenta n-6/n-3 PUFA ratio is associated with visceral adiposity and cardiovascular risk in the offspring at 6 years of age
    
    hrp0094p2-237
  - Analysis of Placental Steroidogenesis as a Cause of Recurrent Miscarriage
    
    hrp0094p2-238
  - Antenatal Markers Related to Fetal Growth Restriction Can Predict Childhood Systolic Blood Pressure
    
    hrp0094p2-239
  - Hypomethylation of the Prader-Willi imprinting control region associates with postnatal growth and visceral adiposity in healthy children
    
    hrp0094p2-240
  - Incidence of early neonatal hypoglycemia and some related risk factors in Qatar. A cohort study over two years (2018 and 2019)
    
    hrp0094p2-241
  - Long-term follow-up in a case with congenital hyperinsulinemic hypoglycemia with a novel p.Ser1389Pro mutation in ABCC8 gene
    
    hrp0094p2-242
  - Postnatal linear growth and weight gain in infants of non-diabetic mothers (INDM) who were born preterm or near term and had significant neonatal hypoglycemia.
    
    hrp0094p2-243
  - Genetic Testing Access and Results for Patients with Congenital Hyperinsulinism as Conducted through the CHI and University of Exeter Partnership
    
    hrp0094p2-244
  - Predictors of short stature in intrauterine growth retardation in a region of north Africa
    
    hrp0094p2-245
- Growth hormone and IGFs
- - Massive Open Online Learning - accelerating knowledge in digital health in the management of children with growth disorders
    
    hrp0094p2-246
  - A girl with concurrent congenital adrenal hyperplasia, isolated growth hormone deficiency type II (IGHD II) and a new mutation in the GH 1 gene - an extremely unusual case
    
    hrp0094p2-247
  - Reduction in pappalysin and stanniocalcin levels explain the decrease in IGF-I bioavailability in anorexia nervosa
    
    hrp0094p2-248
  - Predictors of short stature in premature infants born small for gestational age
    
    hrp0094p2-249
  - Patterns of suboptimal adherence to growth hormone treatment in children living in Italy
    
    hrp0094p2-250
  - Screening of celiac disease among children with growth hormone deficiency and idiopathic short stature
    
    hrp0094p2-251
  - Pappalysins and stanniocalcins in prenatal and postnatal life
    
    hrp0094p2-252
  - GROWPATI Study: Growth and puberty description pattern in a well-characterized cohort of patients with growth retardation due to severe primary IGF1 deficiency
    
    hrp0094p2-253
  - Clinic, laboratory and prognostic findings of patients who are diagnosed by Kowarski syndrome (biologically inactive growth hormone)
    
    hrp0094p2-254
  - Prevalence of insulin-like growth factor 1 (IGF1) deficiency in prepubertal children with isolated short stature (ISS) and their response to GH therapy.
    
    hrp0094p2-255
  - Thyroid function (TF) in short children with idiopathic short stature (ISS) treated with growth hormone (GH)versus those not treated; a controlled study.
    
    hrp0094p2-256
  - Investigating the impact of the TuiTek patient support programme, designed to support caregivers of children prescribed recombinant human growth hormone treatment for growth hormone deficiency in Taiwan: A pilot study
    
    hrp0094p2-257
  - Incidence of ALS deficiency in patients with growth hormone deficiency at tertiary pediatric endocrinology center
    
    hrp0094p2-258
  - Presentation of IGF-1/IGFBP-3 molar ratio as an effective monitoring index during treatment of growth hormone deficient patients
    
    hrp0094p2-259
  - Current growth hormone therapy practices in Belgium for the treatment of short children born small for gestational age
    
    hrp0094p2-260
  - Increased height and IGF1 serum levels in children with non-neurofibromatosis type 1 gliomas
    
    hrp0094p2-261
  - A Survey on Clinician Perceptions of Long-Acting Growth Hormone Analogs
    
    hrp0094p2-262
  - Pituitary gland volume measured by Magnetic Resonance Imaging as diagnostic predictor of persistent Childhood-onset growth hormone deficiency
    
    hrp0094p2-263
  - Growth hormone (GH) treatment of children with idiopathic short children (ISS) with normal insulin-like growth factor-1 (IGF-1) versus those with low IGF-I at diagnosis.
    
    hrp0094p2-264
  - Growth response to growth hormone therapy in growth hormone deficient (GHD) children in relation to the distance between their height SDS (HtSDS) and their mid-parental height.
    
    hrp0094p2-265
  - Linear growth and response to GH therapy in children with short stature with normal Growth hormone secretion: Comparison between children with delayed versus no delay in the bone age at diagnosis.
    
    hrp0094p2-266
  - Linear growth and response to GH therapy in children with GHD with normal IGF-I versus those with normal GH secretion associated with low IGFI at presentation.
    
    hrp0094p2-267
  - Growth response to growth hormone therapy in short children in relation to their distance from mid-parental heights (MPHt).
    
    hrp0094p2-268
  - Immunogenicity of recombinant growth hormone therapy in the children with short stature and consequences on growth-promoting effect
    
    hrp0094p2-269
  - Unified training materials to improve adherence to GH-treatment
    
    hrp0094p2-270
  - Linear growth of prepubertal children born small for gestational age on growth hormone therapy for 3 years
    
    hrp0094p2-271
  - Evaluation of the clinical and laboratory parameters and final adult height in patients treated with recombinant human growth hormone.
    
    hrp0094p2-272
  - The results of treatment with growth hormone in a patient with growth hormone deficiency and type 1 diabetes
    
    hrp0094p2-273
  - Aetiology and different clinical conditions of GHD in children in a region of North Africa
    
    hrp0094p2-274
  - Growth hormone therapy in short stature: The variability of responses to treatment after one year. About 41 cases
    
    hrp0094p2-275
  - Growth Hormone Resistance; The Iraqi experience
    
    hrp0094p2-276
- Growth and syndromes (to include Turner syndrome)
- - Response to growth hormone therapy with high IGF-1-levels and severe insulin resistance in two-cases with SOFT syndrome: A novel homozygous mutation in POC1A
    
    hrp0094p2-277
  - Effects of growth hormone therapy on serum concentrations of IGF-1 in patients with Turner syndrome: High IGF-1 concentrations despite optimal dose?
    
    hrp0094p2-278
  - The Effect of Hospital Admission and Nutritional Rehabilitation (NR) on Growth and Metabolic abnormalities in adolescent females with severe Anorexia Nervosa (AN)
    
    hrp0094p2-279
  - Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status
    
    hrp0094p2-280
  - Endocrinological assessment in patients with fanconi anemia
    
    hrp0094p2-281
  - Brain-derived neurotrophic factor and matrix metalloproteinases as markers of metabolic status in girls with Turner syndrome.
    
    hrp0094p2-282
  - Assessment of genetic defects, baseline characteristics and adverse events reported in the Increlex® registry
    
    hrp0094p2-283
  - Associations between height and health-related quality of life (HRQoL) and functional independence in children with achondroplasia
    
    hrp0094p2-284
  - COVID 19 impact on Pediatric Endocrinology care - a short story from Romania
    
    hrp0094p2-285
  - Single nucleotide variations associated with short stature in Baka Pygmies as identified by Whole Exome Sequence (WES)
    
    hrp0094p2-286
  - Novel LZTR1 mutations in subjects with features of Noonan Syndrome and GH insensitivity negatively regulate GH-induced IGF-I production and hyperactivate GH-induced ERK1/2 activation in response to GH in vitro
    
    hrp0094p2-287
  - Comorbidities in Turner Syndrome patients controlled in our center since the 80’s
    
    hrp0094p2-288
  - Familial Mosaic Turner Syndrome with short stature and spontaneous puberty due to a ring X chromosome with distal Xp22.3 and distal Xq26 deletion
    
    hrp0094p2-289
  - Linear growth response to growth hormone therapy in underweight versus normal-weight children with idiopathic short stature (ISS)
    
    hrp0094p2-290
  - Linear Growth and Weight gain in Infants with Significant Neonatal Hypoglycemia during the first two years of age: Comparison of infants of Diabetic Mothers (IDM) versus infants of non-diabetic mothers (INDM) with transient hyperinsulinemia (non-ketotic hypoglycemia)
    
    hrp0094p2-291
  - Timing of infancy-childhood growth spurt in healthy Turkish children
    
    hrp0094p2-292
  - Effects of GH replacement therapy on body composition and muscle health in children and adolescents with GH deficiency: one-year prospective case-control study.
    
    hrp0094p2-293
  - The spectrum of the Prader-Willi-like pheno- and genotype
    
    hrp0094p2-294
  - An Italian survey on GH stimulation tests and their adverse side effects.
    
    hrp0094p2-295
  - Comparing the efficacy of nutritional supplementation of different caloric concentrations on linear growth and weight gain in late childhood, a longitudinal study.
    
    hrp0094p2-296
  - The efficacy and safety of recombinant biosimilar growth hormone treatment in children with GHD and SGA: a Czech retrospective national longitudinal study
    
    hrp0094p2-297
  - A qPCR based approach for rapid detection of Turner Syndrome and its variants
    
    hrp0094p2-298
  - Case report: Tall stature, obesity and hip dysplasia in Weaver syndrome due to a loss-of-function variant in EHZ2
    
    hrp0094p2-299
  - Association of Daily Growth Hormone Injection Adherence and Height among Children with Growth Hormone Deficiency
    
    hrp0094p2-300
  - The evaluation of growth velocity, height, weight, elementary laboratory tests and hormonal function in the patient with Floating-Harbor syndrome treated with growth hormone for 20 months -case report, preliminary report.
    
    hrp0094p2-301
  - Two Sibling Cases with Growth Hormone Receptor Mutation: Variable Clinical Expressivity in Laron Syndrome
    
    hrp0094p2-302
  - A literature review of the potency and selectivity of FGFR-selective tyrosine kinase inhibitors, such as infigratinib, in the potential treatment of achondroplasia
    
    hrp0094p2-303
  - Impact of estrogen therapy on pubertal growth in Turner syndrome
    
    hrp0094p2-304
  - Anastrozole improves height prediction and near final height as monotherapy or in combination with growth hormone
    
    hrp0094p2-305
  - Growth hormone deficiency (GHD) with high circulating insulin-like growth factor-1 (IGF-1) in an adolescent with celiac disease: Is it IGF-1 insensitivity?
    
    hrp0094p2-306
  - Postnatal Linear Growth and Weight Gain in Infants of Diabetic Mothers (IDM) Who Were Born at or Near Term and Had Severe Neonatal Hypoglycemia Without Other Comorbidities.
    
    hrp0094p2-307
  - Evidence that non-syndromic familial tall stature has an oligogenic origin including ciliary genes
    
    hrp0094p2-308
  - Early-onset growth hormone treatment in Prader-Willi syndrome attenuates the risk of transition to severe obesity
    
    hrp0094p2-309
  - Incidental pituitary adenoma detection in two patients affected by Williams Syndrome: only a coincidence?
    
    hrp0094p2-310
  - Efficacy of recombinant growth hormone therapy in TRPS 1 syndrome coexisting with growth hormone deficiency.
    
    hrp0094p2-311
  - Results from the Implementation of a Growth Disorders Related Twinning Programme (Partners4Growth) at tertiary pediatric endocrinology clinics
    
    hrp0094p2-312
  - Co-occurrence of Turner (46,X-ring/45,X0 mosaicism) and Mayer-Rokitansky-Kuster-Hauser Syndromes: a case report
    
    hrp0094p2-313
  - Shox Gene Pathologies In Children With Short Stature And Madelung Deformity
    
    hrp0094p2-314
  - Characteristics of Patients with Noonan Syndrome Carrying a PTPN11 Mutation: The Recombinant Growth Hormone Treatment and Long-Term Follow-up
    
    hrp0094p2-315
  - Determining factors of a good response to treatment with growth hormone for the first 2 years
    
    hrp0094p2-316
  - Noonan syndrome patients with short stature at a single pediatric endocrinology centre
    
    hrp0094p2-317
  - Thyroid status in children with Turner syndrome
    
    hrp0094p2-318
  - Rare case report: A Chinese boy with MDPL syndrome cause by POLD1 gene mutation
    
    hrp0094p2-319
  - An Unusual Case of Gastrointestinal Bleeding; Expecting the Unexpected
    
    hrp0094p2-320
  - Alterations in Metabolic profile and Body Composition in children with Silver Russell syndrome
    
    hrp0094p2-321
  - Growth abnormalities in patients with Type 1 diabetes
    
    hrp0094p2-322
  - A novel CEP57 mutation of mosaic variegated aneuploidy syndrome in a Chinese girl: a case report and review of literature
    
    hrp0094p2-323
  - A Patient with Turner Syndrome (45X/46XX) and Congenital Adrenal Hyperplasia: A Case Report and Literature Review
    
    hrp0094p2-324
  - Impact of oral nutritional supplements on growth outcomes in underweight children (5: 12 years) with no systemic disease.
    
    hrp0094p2-325
  - Differential diagnosis of pre- and postnatal short stature revisited: 3-M syndrome
    
    hrp0094p2-326
  - A case of a Floating-Harbor syndrome in a child with severe short stature.
    
    hrp0094p2-327
  - Excessive body hair, short stature and advanced bone age in a girl: Hypertrichosis versus adrenarche?
    
    hrp0094p2-328
  - Cornelia de Lange syndrome: a case report
    
    hrp0094p2-329
  - Short stature and efficacy of growth hormone treatment in a child with Nail-Patella Syndrome. A case report.
    
    hrp0094p2-330
  - Final and Near-final Adult Height and BMI after Long-term Growth Hormone Treatment in Patients with Turner Syndrome (TS)
    
    hrp0094p2-331
  - Evaluating Safety, Efficacy, and Pharmacokinetics of Weekly TransCon CNP in Children with Achondroplasia: Design of the ACcomplisH Trial
    
    hrp0094p2-332
- Multisystem endocrine disorders
- - An Early Diagnosis of Prohormone Convertase Deficiency
    
    hrp0094p2-333
  - Serologic Testing for Celiac Disease and Gluten Intolerance in a Singaporean paediatric endocrine and growth clinic.
    
    hrp0094p2-334
  - Obesity, vaginal bleeding and ovarian mass in a 5-year-old female girl with autoimmune hypothyroidism
    
    hrp0094p2-335
  - Endocrine and metabolic complications according to genotype in Prader-Willi syndrome
    
    hrp0094p2-336
  - Van Wyk Grumbach Syndrome in an Egyptian Female Pediatric Patient: a rare presentation of a common disease
    
    hrp0094p2-337
  - Diagnostic and Follow-up Problems of Medical Care for Prader-Willi Syndrome Children in Resourse-Limited Settings
    
    hrp0094p2-338
  - Three generations of MEN-1: the importance of family screening
    
    hrp0094p2-339
  - Follow-up and management of endocrine and metabolic disorders after hematopoietic stem cell transplantation in a patient followed for Fanconi anemia
    
    hrp0094p2-340
  - Neonatal McCune Albright Syndrome Presenting with Diabetes Mellitus
    
    hrp0094p2-341
  - Combined pituitary hormone deficiency associated with Graves’ disease
    
    hrp0094p2-342
  - Autoimmune polyendocrine syndrome type 2 and precocious puberty: a rare association
    
    hrp0094p2-343
  - Thermoregulatory delays in Greek PCOS adolescents
    
    hrp0094p2-344
  - Endocrine manifestations in familial neurofibromatosis type 1: a case report
    
    hrp0094p2-345
- Pituitary, neuroendocrinology and puberty
- - The clinical and biochemical spectrum of pituitary lesions in children compared to adults: experience from a single tertiary center
    
    hrp0094p2-346
  - Optic tract glioma and endocrine disorders- comparison between patients with and without NF1- a single center experience
    
    hrp0094p2-347
  - Endocrine manifestations of paediatric intracranial germ cell tumour: from diagnosis to long-term follow-up
    
    hrp0094p2-348
  - Machine learning to detect the Klinefelter syndrome endocrine profile
    
    hrp0094p2-349
  - Nuchal Skinfold Thickness in Pediatric Brain Tumor Patients
    
    hrp0094p2-350
  - Growth hormone deficiency in 52 children with brain Magnetic Resonance Imaging Abnormalities
    
    hrp0094p2-351
  - Patients with PWS and related syndromes display differentially methylated regions involved in neurodevelopmental and nutritional trajectory.
    
    hrp0094p2-352
  - Clinical course of primary empty sella in children: a 10-year single-center experience
    
    hrp0094p2-353
  - Relation between specific pubertal growth and breast maturation - a longitudinal study in healthy girls
    
    hrp0094p2-354
  - Did Central Precocious Puberty Increase in COVID 19 Pandemic?
    
    hrp0094p2-355
  - Delayed diagnosis of paediatric intracranial germ cell tumour (IC-GCTs)
    
    hrp0094p2-356
  - Gonadotropin-releasing hormone analog treatment in children with idiopathic central precocious puberty: a pharmacovigilance study in a pediatric population.
    
    hrp0094p2-357
  - Pubertal induction in girls with hypogonadism: preliminary prospective data of efficacy in patients with/without initial overnight estrogen replacement
    
    hrp0094p2-358
  - Evaluation of pituitary/cranial imaging results of central-puberty precocious cases
    
    hrp0094p2-359
  - In vivo magnetic resonance spectroscopy as a non-invasive tool for the identification of a sellar tumour in a boy with precocious puberty.
    
    hrp0094p2-360
  - Rahman Syndrome: Hypopituitarism might be responsible for changing height pattern
    
    hrp0094p2-361
  - Congenital hypopituitarism: the role of genetics
    
    hrp0094p2-362
  - Pedigree analysis is essential for clarifying oligogenic transmission in a family with congenital hypogonadotropic hypogonadism (CHH)
    
    hrp0094p2-363
  - Congenital hypogonadotropic hypogonadism associated with X-linked ichthyosis due to X-chromosome microdeletion identified by chromosomal microarray
    
    hrp0094p2-364
  - Gonadotropin Flare with Different Depot GnRH Agonists: Comparative Analysis.
    
    hrp0094p2-365
  - Hypothalamic obesity in children with craniopharyngioma
    
    hrp0094p2-366
  - Duplication of Pituitary Gland-plus Syndrome presenting with a Transcranial Nasal Dermoid Cyst
    
    hrp0094p2-367
  - Sterile Abscess Formation with Two Different GnRH Analogues: Three Case Reports
    
    hrp0094p2-368
  - 6-Month GnRHa Formulations Are a Good Choice During the COVID-19 Pandemic and Beyond
    
    hrp0094p2-369
  - Size Matters: CAG Repeat Length of the Androgen Receptor Gene, Testosterone, and Male Adolescent Depression Severity
    
    hrp0094p2-370
  - Is quail egg a potential endocrine disruptor?
    
    hrp0094p2-371
  - The impact of the Covid-19 pandemic on the UK National Hypothalamic-pituitary Axis Tumour (HPAT) multidisciplinary meeting
    
    hrp0094p2-372
  - Evaluation of Clinical, Laboratory and Radiological Findings in the Differential Diagnosis of Premature Telarche and Central Puberty Precocious
    
    hrp0094p2-373
  - Crooke Cell Adenoma as a Rare Cause of Recurrent Cushing Disease: A Challenge in Treatment and Follow-up
    
    hrp0094p2-374
  - Salivary sex steroids as markers of puberty in boys during late childhood and adolescence
    
    hrp0094p2-375
  - Efficacy of cabergoline in the treatment of pituitary macroadenoma complicated in a 14-year-old girl.
    
    hrp0094p2-376
  - Use of Tolvaptan in a child with SIADH post pituitary surgery
    
    hrp0094p2-377
  - The effect of 3 years of Gonadotropin-Suppressive Therapy in Girls with Early Puberty: Height Z Score in Relation to Mid-Parental height Z score.
    
    hrp0094p2-378
  - An Observational, Retrospective Study to Evaluate Long Term Safety and Effectiveness of Leuprorelin in the Treatment of Central Precocious Puberty
    
    hrp0094p2-379
  - Abstract unavailable
    
    hrp0094p2-380
  - Characterization of puberty development in a large cohort of patients with Noonan syndrome with molecular diagnosis
    
    hrp0094p2-381
  - Pituitary tumors in children and adolescents: clinical and etiological profile
    
    hrp0094p2-382
  - Langerhans Cell Histiocytosis with Isolated Central Diabetes Insipidus, Low Grade Fever and Sellar Erosion
    
    hrp0094p2-383
  - Basal LH as a screening test for diagnosis of central precocious puberty
    
    hrp0094p2-384
  - A Practical Method for the Evaluation of Childhood Hypophysitis: Pituitary Stalk/Basilary Artery Ratio
    
    hrp0094p2-385
  - Blood Pressure in Girls with Central Precocious Puberty and GnRH Analog Therapy
    
    hrp0094p2-386
  - Isolated central diabetes insipidus and periventricular nodular heterotopia in a 9-year-old girl
    
    hrp0094p2-387
  - Central precocious puberty: clinical, etiologic and therapeutic features
    
    hrp0094p2-388
  - Atypical Presentation of Pituitary Macroadenoma in an adolescent girl: Central Hypothyroidism and Attenuated Pubertal Growth Spurt.
    
    hrp0094p2-389
  - A case of partially Empty Sella with hypopituitarism in a child
    
    hrp0094p2-390
  - Cushing’s disease in paediatric patients: Diagnosis and evolution
    
    hrp0094p2-391
  - Late Puberty In Children
    
    hrp0094p2-392
  - First Morning Voided Urinary Gonadotropin Measurements for the Early Screening, Diagnosis and Follow-up of Central Precocious Puberty Patients
    
    hrp0094p2-393
- Sex differentiation, gonads and gynaecology or sex endocrinology
- - SRY negative 46XX male syndrome: case report
    
    hrp0094p2-394
  - Cognitive function and linear growth in Prednisone-treated children with salt-wasting congenital adrenal hyperplasia
    
    hrp0094p2-395
  - Combining big data science with clinics: Novel approach for understanding human sex development and its variants.
    
    hrp0094p2-396
  - Vascular dysfunction and increased cardiovascular risk in hypospadias
    
    hrp0094p2-397
  - Evaluation of genomic copy number variations in the etiology of syndromic patients with diferences of sex development (DSD)
    
    hrp0094p2-398
  - Self-reported Feelings of Adult Patients with Differences of Sex Development (DSD) Regarding Genital Surgical Procedures
    
    hrp0094p2-399
  - Peripheral Precocious Puberty in girls affected by McCune-Albright Syndrome: safety and efficacy retrospective study on letrozole treatment
    
    hrp0094p2-400
  - Two sisters with primary hypergonadotrophic hypogonadism, pubertal progress and deletion of 61.5MB of Χq21.33q28 region
    
    hrp0094p2-401
  - Description of a new variant in the MAMLD1 gene in an infant with microphallus and hypospadias
    
    hrp0094p2-402
  - Surgical aspects of the multicentric and interdisciplinary study in minors with different sexual development
    
    hrp0094p2-403
  - Is inflammation the major driver of polycystic ovary syndrome (PCOS)? A proteomic approach to understanding PCOS in adolescents and the search for novel non-invasive biomarkers
    
    hrp0094p2-404
  - Serum high mobility group box 1 (HMGB1) levels are independently associated with glucose clamp-derived measures of insulin resistance in PCOS
    
    hrp0094p2-405
  - ZSWIM7 is associated with human female meiosis and familial primary ovarian insufficiency
    
    hrp0094p2-406
  - Is the recommended dual therapy for transsexual boys harmless?
    
    hrp0094p2-407
  - Plexiform neurofibroma of the penis as an infrequent manifestation debut in a pediatric patient
    
    hrp0094p2-408
  - Surprising X Chromosomes: Unusual Mosaicism
    
    hrp0094p2-409
  - Puberty delay in girls: etiological structure of the disease
    
    hrp0094p2-410
  - Rationale for a reduced dexamethasone dose in prenatal congenital adrenal hyperplasia therapy based on pharmacokinetic modelling
    
    hrp0094p2-411
  - 45,X/46,XY mosaicism: Phenotypic characteristics, growth, and gonadal features
    
    hrp0094p2-412
  - Challenges faced by children and adolescents with Differences in Sex Development (DSD) managed at a tertiary care specialized university center in Sri Lanka
    
    hrp0094p2-413
  - A novel mutation of SOX2 gene in an idiopathic hypogonadotropic hypogonadism patient with olfactory bulb agenesis
    
    hrp0094p2-414
  - Obesity, ovarian mass, vaginal bleeding and hypothyroidism in a 5-year-old female girl
    
    hrp0094p2-415
  - Ovarian Juvenile Granulosa Cell Tumor in 9-Month-Old female Infant presented with Isosexual Pseudo Puberty: Case Report
    
    hrp0094p2-416
  - A case report of Non-syndromic 46, XX testicular DSD presenting as a genital ambiguity - Clinical, molecular and cytogenetic analysis
    
    hrp0094p2-417
  - 46 XX, SRY negative testicular DSD presenting with VACTERL Syndrome
    
    hrp0094p2-418
  - A late revelation of Sexual differentiation disorder 46XX due to 11 beta hydroxylase deficiency
    
    hrp0094p2-419
  - Gonadal tumor risk, bone mineral density, and genetics, clinical, hormonal, and psychosexual aspects of a large androgen insensitivity syndrome cohort
    
    hrp0094p2-420
  - Radiological evaluation of children with atypical genitalia due to disorders of sex development (46, XY DSD) in a resource-limited setup
    
    hrp0094p2-421
  - 17-hydroxylase deficiency and diabetes in a case with 46 XY female
    
    hrp0094p2-422
  - Diagnostic dilemma in a patient with central precocious puberty: Ovarian steroid cell tumor
    
    hrp0094p2-423
  - Dimensional approach to gender dysphoria in nigeria: Association with socio-demographics and psycho-sexual variables
    
    hrp0094p2-424
  - Puberty delay in girls: Analyses of disease structure depending on clinical characteristics
    
    hrp0094p2-425
  - Uterus agenesia in a patient with CATCH 22 Syndrome. Purpose of a case
    
    hrp0094p2-426
  - High throughput screening of DSD candidate genes with the help of the powerful model Drosophila melanogaster
    
    hrp0094p2-427
  - Case series: Use of tamoxifen in the management of gynaecomastia in three adolescent boys with 46 XY DSD
    
    hrp0094p2-428
  - 4-year-old female patient with mixed germ cell tumor and underlying Cowden syndrome
    
    hrp0094p2-429
  - A comparison between Androstanolone and Testosterone Enanthate for penile augmentation in patients with idiopathic micropenis
    
    hrp0094p2-430
  - Combination therapy of hypogonadotropic hypogonadism with rFSH and hCG – case report
    
    hrp0094p2-431
  - 46,XY DSD due to biallelic DHX37 gene mutations
    
    hrp0094p2-432
  - Novel mutation in an iranian family with 17-β hydroxysteroid dehydrogenase type 3 deficiency
    
    hrp0094p2-433
  - A case of gender developmental disorder with difficulty in molecular diagnosis: New variant in NR5A1 gene
    
    hrp0094p2-434
  - Two pedigrees with congenital bilateral anorchia in one sibling and testicular torsion at adolescence in another: a shared genetic predisposition?
    
    hrp0094p2-435
  - Importance of testicular biopsy for validation of diagnosis; cryptorchidism, analyzing prescrotal undescended testes
    
    hrp0094p2-436
  - Rare genetic disorder associated with microphallus
    
    hrp0094p2-437
  - Congenital adrenal hyperplasia in detail: A multicentric and interdisciplinary study in minors with different sexual development
    
    hrp0094p2-438
  - Sex assignment at birth: is it always easy?
    
    hrp0094p2-439
  - Combination therapy of hypogonadotropic hypogonadism in boys with rFSH and hCG – case reports analyses
    
    hrp0094p2-440
  - Clinical case of premature ovarian failure in combination with blepharophimosis-ptosis-epicanthus inversus due to mutation in FOXL2 gene
    
    hrp0094p2-441
  - Persistent Müllerian duct syndrome presenting with bilateral cryptorchidism and obstructed inguinal hernia
    
    hrp0094p2-442
  - 5 alpha-reductase type 2 deficiency: A case report
    
    hrp0094p2-443
  - An unexplained cause of unilateral gynecomastia in a 3-year-old boy
    
    hrp0094p2-444
  - Could intramuscular testosterone differentiate between partial androgen insensitivity and 5 alpha reductase type 2 deficiency?
    
    hrp0094p2-445
- Thyroid
- - The efficacy and short- and long-term side effects of radioactive iodine treatment in pediatric Graves’ disease: a systematic review
    
    hrp0094p2-446
  - Incidentally detected papillary thyroid cancer with elevated calcitonin in a 15 year-old female: A case report
    
    hrp0094p2-447
  - Methimazole-induced remission rates in pediatric graves’ disease: A systematic review
    
    hrp0094p2-448
  - Congenital multinodular goiter causing acute airway obstruction in a newborn: a case report
    
    hrp0094p2-449
  - Initial response to thionamide medication in young people with newly diagnosed thyrotoxicosis
    
    hrp0094p2-450
  - A girl with Trisomy 21 presents with Van Wyk-Grumbach syndrome. A rare diagnosis
    
    hrp0094p2-451
  - Complications after pediatric thyroidectomy: lymph node dissection is a risk factor for permanent hypocalcemia
    
    hrp0094p2-452
  - Kinetics of FT4 serum concentrations in newborns and infants with congenital hypothyroidism during follow-up differ in the three severity groups
    
    hrp0094p2-453
  - Thyroid dysfunction in small for gestational age infants: a need for second screening?
    
    hrp0094p2-454
  - Expression of Zinc transporter 8 in thyroid tissues from patient with immune and non-immune thyroid diseases
    
    hrp0094p2-455
  - Hashimoto Thyroiditis: long term follow-up from childhood to young adulthood
    
    hrp0094p2-456
  - A case of complete atrioventricular block after initiation of methimazole in a patient with Graves' disease associated with Down's syndrome previously undergoing cardiac surgery
    
    hrp0094p2-457
  - Unilateral autoimmune ophthalmopathy as a first symptom in manifestation of autoimmune thyroiditis and systemic lupus erythematosus in an adolescent girl. Case report.
    
    hrp0094p2-458
  - Incidence and etiology of primary congenital hypothyroidism in Flanders
    
    hrp0094p2-459
  - Re-evaluation of the prevalence of permanent congenital hypothyroidism in Niigata, Japan: A retrospective study
    
    hrp0094p2-460
  - Early reassessment in congenital hypothyroidism
    
    hrp0094p2-461
  - Growth impairment in children with severe autoimmune primary hypothyroidism and pituitary hyperplasia without goiter
    
    hrp0094p2-462
  - The Use Of Intravenous Introduction Of Glucocorticoids In The Active Stage Of Graves’ Ophthalmopathy In Childhood. Clinical Case
    
    hrp0094p2-463
  - Atypical presentation of acute suppurative thyroiditis in a 6 year old child
    
    hrp0094p2-464
  - Allan-Herndon-Dudley syndrome: case report of a rare disorder
    
    hrp0094p2-465
  - Abstract unavailable
    
    hrp0094p2-466
  - Abstract unavailable
    
    hrp0094p2-467
  - Thyroid function in preterm infants admitted to the neonatal intensive care unit: a single center study
    
    hrp0094p2-468
  - Thyroid dysfunction in Beta-thalassemia patients
    
    hrp0094p2-469
  - Victim pathologies of the pandemic. Severe acquired hypothyroidism
    
    hrp0094p2-470
  - Mitigating thyroid cancer risk in multinodular hyperplasia secondary to a 10q23.31 deletion (PTEN Hamartoma Tumour Syndrome)
    
    hrp0094p2-471
  - Thyroid dysfunction and autoimmune thyroiditis in children with new-onset diabetes mellitus
    
    hrp0094p2-472
  - A rare cause of congenital hypothyroidism: Brain-lung-thyroid syndrome
    
    hrp0094p2-473
  - Recurrent fractures in a child with Graves' disease
    
    hrp0094p2-474
  - Case study of 13- year-old boy suffering from papillary thyroid cancer in stage pT3aN1bMX
    
    hrp0094p2-475
  - Evaluation of general characteristics of children with hypothyroidism
    
    hrp0094p2-476
  - L-T4 absorption test in 14-year-old patient with severe refractory hypothyroidism after total thyroidectomy
    
    hrp0094p2-477
  - A child with anti-thyroid arthritis syndrome
    
    hrp0094p2-478
  - Thyroglobulin deficiency: a rare cause of neonatal stridor
    
    hrp0094p2-479
  - TBG deficiency and Central Congenital Hypothyroidism (CCH): Our experience in neonatal screening with TSH and T4
    
    hrp0094p2-480
  - A case of hypothyroidism post bone marrow transplantation
    
    hrp0094p2-481
  - Iodine status and autoimmune thyroiditis in children; a case-control study in Sri Lanka
    
    hrp0094p2-482
  - A 9-year-old girl with Van Wyk and Grumbach syndrome: precocious puberty as a rare consequence of hypothyroidism
    
    hrp0094p2-483
  - Iodine Deficiency Cretinism in Tuva Republic
    
    hrp0094p2-484
  - Prevalence and associated factors of Congenital Hypothyroidism in Bogotá, Colombia. 2014 - 2020
    
    hrp0094p2-485
  - Aetiology and different clinical condition of hypothyroidism in children and adolescents
    
    hrp0094p2-486
  - Influenza A induced Thyrotoxic Storm Post Haematopoietic Stem Cell Transplantation
    
    hrp0094p2-487
  - The state of iodine deficiency in Krasnoyarsk territory according to results of neonatal TSH screening in 2019
    
    hrp0094p2-488
  - Thyrotropic cell hyperplasia secondary to prolonged uncontrolled primary hypothyroidism
    
    hrp0094p2-489
  - Thyroid dyshormonogenesis: a case report of two siblings with a heterozygous variant in the TPO gene.
    
    hrp0094p2-490
  - Pediatric Graves’ disease in southern Tunisia
    
    hrp0094p2-491

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Abstracts

59th Annual ESPE (ESPE 2021 Online)

Contents

BiosciAbstracts